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DNA adducts, which block replicative DNA polymerases (DNAPs), are often bypassed by lesion-bypass DNAPs, which are mostly
in the Y-Family. Y-Family DNAPs can do non-mutagenic or mutagenic dNTP insertion, and understanding this diﬀerence is
important, because mutations transform normal into tumorigenic cells. Y-Family DNAP architecture that dictates mechanism, as
revealed in structural and modeling studies, is considered. Steps from adduct blockage of replicative DNAPs, to bypass by a lesion-
bypass DNAP, to resumption of synthesis by a replicative DNAP are described. Catalytic steps and protein conformational changes
are considered. One adduct is analyzed in greater detail: the major benzo[a]pyrene adduct (B[a]P-N
2- d G ) ,w h i c hi sb yp a s s e dn o n -
mutagenically (dCTP insertion) by Y-family DNAPs in the IV/κ-class and mutagenically (dATP insertion) by V/η-class Y-Family
DNAPs. Important architectural diﬀerences between IV/κ-class versus V/η-class DNAPs are discussed, including insights gained
by analyzing ∼400 sequences each for bacterial DNAPs IV and V, along with sequences from eukaryotic DNAPs kappa, eta and
iota. The little ﬁnger domains of Y-Family DNAPs do not show sequence conservation; however, their structures are remarkably
similar due to the presence of a core of hydrophobic amino acids, whose exact identity is less important than the hydrophobic
amino acid spacing.
1.Introduction
DNA damaging agents (genotoxins) cause mutations that
initiate tumor formation, which makes sense given that
tumor cells have mutations in key growth control genes that
lead to improperly regulated cell growth [1, 2]. The steps
leading to mutagenesis vary depending on the genotoxin,
but the paradigm in Figure 1 illustrates many of the
typical steps using one particularly well-studied chemical
carcinogen benzo[a]pyrene [3–5]. At the apex of this process
are DNA adducts, which, if they are not removed by DNA
repair, usually block replicative DNA polymerases (DNAPs).
To overcome such potentially lethal blockage, cells have
DNAPs that do translesion synthesis (TLS) past these DNA
lesions/adducts [6–22].
Cells possess many DNAPs; for example, human cells,
yeast (S. cerevisiae)a n dE. coli have at least ﬁfteen, eight
and ﬁve, respectively, [6–22]. Most TLS-DNAPs are in
the Y-Family [6–22], where humans have three template-
directed members (hDNAPs η, ι,a n dκ), yeast has one
(scDNAP η), and E. coli has two (ecDNAPs IV and V).
Y-Family DNAPs have a conserved ∼350aa core, which
includes the polymerase active site (representative refer-
ences [23–40]). As with all DNA polymerases, Y-Family
members resemble a right-hand with thumb, palm, and
ﬁngers domains, although their “stubby” ﬁngers and thumb
result in more solvent accessible surface around the tem-
plate/dNTP binding pocket [19], which is undoubtedly
the case to accommodate the bulky and/or deforming
DNA adducts/lesions that protrude into these open spaces
during bypass. Y-Family DNAPs grip DNA with an addi-
tional domain, which is usually called the “little ﬁnger
domain” or the “polymerase-associated domain” (PAD)
[23–25].2 Journal of Nucleic Acids
Y-Family DNAPs are found in all three domains of
life, bacteria, archaea, and eukaryotes, which undoubtedly
reﬂects the fact that all cells face the same issues when
confronting the need to replicate past DNA damage. The
pattern of TLS is often strikingly similar in diﬀerent
cell types. For example, human DNAP κ was originally
discovered because its sequence closely resembles E. coli
DNAP IV [41–43], and dNTP insertion opposite a variety of
adducts/lesionsisremarkablysimilarfortheDNAPIV/κpair
(Table1),suggestingtheyarefunctionalorthologs(discussed
in [44]). E. coli DNAP V and human DNAP η are also
functional orthologs, based on their similarity of dNTP
insertionoppositeavarietyofadducts/lesions(Table1,[44]).
Cases have been made that the IV/κ-class is present in cells
to bypass endogenously generated N2-dG adducts, and the
V/η-class is present to bypass UV-induced photoproducts, as
discussed below.
B-Family DNAPs can also be involved in TLS, such as
DNAP II in E. coli and REV3 (the polymerase subunit of
DNAP ζ), which is present in most eukaryotes [6, 7, 13–15].
B-family TLS-DNAPs are involved in a DNA repair process
involving some interstrand DNA cross-links [45–49] and in
TLS of some adduct/lesions (see below).
Herein, we reﬂect principally on how structural architec-
ture of Y-family DNAPs might aﬀect their mechanism as it
relates to cellular function, in particular why lesion-bypass is
sometimes nonmutagenic and other times it is mutagenic.
Extensive reviews that focus more on the cell biology,
regulationandphenomenologyhaveappearedrecentlyforY-
Family DNAPs from bacteria [21, 22] and eukaryotes [7–12].
2. TranslesionSynthesis DNA
Polymerases in E. coli
E. coli h a sp r o v e nt ob ea ne x c e l l e n tm o d e ls y s t e mt os t u d y
many aspects of the bypass of DNA adducts/lesions by TLS-
DNAPs. E. coli has two Y-Family DNA polymerases: DNAP
IV(dinBgene,351aa,39.5kDa)andDNAPV,whichconsists
of one subunit of UmuC (umuC gene, 422aa, 47.7kDa) and
two subunits of UmuD’ (see below). UmuD’ is derived from
UmuD (umuD gene, 139aa, 15kDa) following autodigestive
removal of its 24 N-terminal aa, when stimulated by RecA∗
[13, 14, 21, 22, 50]. DNAP II (polB gene, 783aa, 90kDa) is
a B-Family lesion bypass DNAP. DNAPs II, IV and V are
each induced as part of the SOS response, which is triggered
by DNA damage and leads to the induction of ∼40 proteins
that help E. coli cope with the damage [50]. The basal and
SOS-induced levels are diﬀerent for each polymerase, where
the [uninduced/induced] levels are [∼40/∼280] for DNAP
II, [∼250/∼2500] for DNAP IV and [∼15/∼200] for DNAP
V[ 51–53]. It seems likely that each of these TLS-DNAP
is present in E. coli principally to overcome the cellular
problems presented by a lesion commonly encountered in
cells as discussed next.
Although DNAP V replicates undamaged templates with
relativelylowﬁdelity (10−3 to 10−4)[54],one striking quality
is its ability to accurately bypass UV photoproducts; for
example, it inserts dATP opposite TT-CPDs [54]. Analysis
of insertion tendencies opposite a variety of adducts/lesions
led to the observation that DNAP V may have two insertion
modes: (i) correct dNTP insertion, and (ii) default dATP
insertion [44]. UV light is a frequently encountered form of
DNA damage for which a TLS-DNAP might be important,
and since TT-CPDs are the major UV lesion [55], a
default dATP insertion mode might help minimize UV
mutagenesis. However, the utilization of this second mode in
other circumstances may have drawbacks. For example, UV
mutagenesis also depends on the umuD/C genes, implying
that DNAP V is required for UV mutagenesis, where C→
T mutations in 5 -PyC sequences predominate, which also
implies dATP insertion (discussed in reference [56]). DNAP
V is involved in other mutagenesis pathways; for example,
it inserts dATP opposite +BP in the G → T mutational
pathway [57], as discussed below. In fact, the preferential
mutagenic insertion of dATP opposite a variety of DNA
lesions in E.colihasbeencalledthe“A-rule”(see[58,59]an d
referencestherein),anditseemslikelythatthisisattributable
to DNAP V’s tendency to insert dATP [44] .B a s e do nl e s i o n -
bypass speciﬁcity (Table 1), E. coli DNAP V appears to be
the functional ortholog of human DNAP η [36], which is
almost certainly responsible for correct bypass of UV-lesions
in human cells and minimizing UV-light mutagenesis that
leads to skin cancer [60–65].
On its own, UmuC, which is the polymerase subunit
of DNAP V, either misfolds or aggregates and is found
in inclusion bodies [22, 50, 66]. UmuC copuriﬁes with
UmuD’, though the yield is invariably low [22, 50, 66].
RecA is also required for eﬃcient DNAP V activity, and
recently, the “DNAP V mutasome” was shown to be a
UmuC/UmuD’2/RecA heterotetramer [67, 68]. The RecA
monomer is added from the 3 -end of a RecA ﬁlament either
in cis or in trans, where the former seems intuitively more
likely, since UmuC/UmuD’2 would encounter a 3 -cis-RecA
at a lesion site, given that RecA ﬁlaments coat ss-DNA on
the downstream side of a lesion-blocked replication fork. To
form RecA ﬁlaments on ss-DNA, SSB must ﬁrst be removed,
which is accomplished by RecFOR [69]. Interestingly, some
evidence suggests that the RecA eukaryotic homolog Rad51
is able to stimulate DNAP η, which is the DNAP V ortholog
[70]. β-clamp also plays a signiﬁcant role with DNAP V as
discussed below.
DNAP IV replicates undamaged DNA only ∼5-fold less
accurately than the catalytic α-subunit of DNAP III [54]. It is
pronetomaking −1frameshiftmutationsinhomopolymeric
runs of six or more G:C base pairs, and base substitutions
also result [22, 71]. DNAP IV’s most striking quality is
its ability to accurately bypass a variety of N2-dG adducts
[72–77]. Methylglyoxal is produced nonenzymatically from
various cellular trioses and forms N2-(1-carboxyethyl)-2 -
dGasitsmajorstableadduct,whichisbypassedaccuratelyby
DNAP IV [76]. Oxidative metabolism forms reactive oxygen
species that generate lipid peroxidation products that give
exocyclic adducts, some of which can ring-open to N2-dG
adductsinds-DNA[78]andmightbebypassedbyDNAPIV,
though this has not been investigated experimentally. These
observations have led several groups to speculate that the
cellular rationale for the genesis of the IV/κ-class of Y-FamilyJournal of Nucleic Acids 3
Table 1: Dominant dNTP insertions opposite various DNA adducts/lesions by E. coli DNAPs IV and V, and human DNAPs κ and η.†
Lesion DNAP V DNAP η DNAP IV DNAP κ
[+ta]-BP-N2-dG A/C A ≥ GC C
AAF-C8-dG C C C/T C/T
AF-C8-dG — — C C
TT-CPD AA AA n n
T(6-4)T AG nG n n
AP site A A n A∗
†Dominant dNTP insertion using puriﬁed DNAPs, where “n” indicates “no” or low activity, “A∗” indicates bypass by an unusual mechanism, and “—”
indicates data unavailable. Data, as reviewed in [44].
DNAPsistheaccuratebypassofN2-dGadductsderivedfrom
various endogenous mechanisms [72, 76].
No analogous story vis-a-vis adducts/lesions has yet
emerged to provide a rationale for the presence of B-family
DNAP II in cells, though one possibility is its involvement
in an accurate DNA repair pathway for interstrand cross-
links [45]. An analogous pathway involving B-family DNAP
ξ exists in eukaryotic cells, and a pathway has been proposed
[46–49].Asdiscussedbelow,DNAPIIfunctionsinotherTLS
pathways.
UmuD2C( n o tU m u D ’ 2C) is thought to slow down
normal DNA replication in response to DNA damage,
thus allowing additional time for lesion removal, which is
considered a DNA damage checkpoint analogous to what
happens in eukaryotic cells [79]. Another mechanism to
accomplish this was recently described: DNAP II or IV
can associate with the DnaB helicase and slow down the
replication fork [80].
The TLS-DNAPs also confer selective advantage on E.
coli during long periods in stationary phase, the so-called
“growth advantage in stationary phase” (GASP) phenotype




Extensive reviews of the cell biology, regulation, and phe-
nomenology of eukaryotic Y-Family DNAPs have appeared
recently [7–12]. Herein, we focus on structural considera-
tions that relate to lesion bypass, though we brieﬂy describe
each of the four subclasses of eukaryotic Y-Family DNAPs:
REV1, DNAP κ,D N A Pη, and DNAP ι.
REV1 is not a traditional template-directed polymerase
and does not use base-base hydrogen bonding. Rather REV1
is a dCTP insertase that ﬂips template dGs out of the helix,
after which dCTP insertion is directed by hydrogen bonding
toaREV1arginineresidue[83].REV1seemstoplayacentral
role in many lesion bypass events as a structural component,
and DNAPs κ, η,a n dι each have REV1 binding domains
[9].
DNAPκistheeukaryoticorthologofDNAPIV(Table1),
and they seem to be present in cells to accurately insert
oppositeN2-dGadducts[84],forexample,DNAPκdeﬁcient
cells are sensitized to killing by benzo[a]pyrene, which
predominantly forms an N2-dG adducts [85]. DNAP κ
uniquely has an N-terminal extension of 100aa called the
“N-clasp” [35]. The N-clasp has three α-helices in a U-shape,
one of which (∼aa30–50) binds on the surface of the ﬁngers
domain, the second of which (∼aa50–75) links the ﬁngers
and thumb domains and lies diagonally across the duplex
region of DNA, and the third traverses the thumb domain
to the usual site of the N-terminus in Y-Family DNAPs.
Removal of the N-clasp signiﬁcantly decreases DNAP κ
polymerase activity [35]. The presence of the N-clasp has
implications for lesion bypass; for example, DNAP κ does
not bypass the N6-dA adduct of benzo[a]pyrene [86], which
has been attributed to a steric clash between the N-clasp and
the pyrene moiety, as revealed in a molecular modeling study
[87]. DNAP κ structure is considered below.
A major role of DNAP η is nonmutagenic bypass of UV
lesions, such as TT-CPDs, and humans deﬁcient in DNAP η
have the cancer-prone syndrome Xeroderma pigmentosum
variant (XPV), which leads to a high incidence of UV-
induced skin cancer [60–65]. Both human and yeast DNAP
η preferentially insert dATP opposite the 5 -T and 3 -T of a
TT-CPD, with misinsertion being higher at the 3 -T, where
dGTP is incorporated ∼3% of the time [88, 89]. Recently,
X-ray structures of a TT-CPD in the active site of yeast
DNAP η [39]a n dh u m a nD N A Pη [40]h a v ee m e r g e d .
These ﬁndings are presented in a separate section(Section 8),
aftercertainprinciplesaboutY-FamilyDNAPsstructurehave
been discussed. DNAP η also plays a role in accurate bypass
oftheoxidativelesion8oxoG[90]andadductsformedbythe
anticancer drug cis-platinum [91].
T h er o l eo fD N A Pι in cells is more enigmatic, though
the fact that deﬁcient cells show enhanced sensitivity to
oxidative damage may be revealing [92]. One interesting
feature of DNAP ι is its propensity to use syn-purines in the
template to form Hoogsteen base pairs syn-A:T and syn-
G:C[36, 37]. A cellular rationale for this is the following.
Oxidative damage leads to lipid peroxidation products,
which form exocyclic adducts that block the Watson-Crick
antiface of the DNA bases. Exocyclic purine adducts in the
syn-conﬁgurationcanstillbasepair throughtheir Hoogsteen
face. The syn-A:T base pair has two hydrogen bonds, just
like anti-A:T. However, both syn-G:C and syn-G:T base
pairs have only one hydrogen bond, unless a proton is
trapped. In a syn-GH+ :C base pair the trapped proton is





























Figure 1: Mutagenesis/carcinogenesis paradigm with benzo[a]pyrene. Steps in the horizontal direction lead toward carcinogenicity, and
include metabolic activation (step 1), reaction with DNA (step 2), adduct mutagenesis (step 3), and tumorigenesis (step 4). Steps in the
vertical direction lead to diminished carcinogenicity, and include metabolic detoxiﬁcation (step 5), carcinogen deactivation (step 6), and
DNA repair (step 7). Diminished carcinogenicity is also associated with other cellular processes, such as delaying the cell cycle and apoptosis
[1].
high (∼3), while a trapped proton in a syn-GH+ :T base
pair would be between O6Ga n dO 4T, whose pKa values are
much lower. Thus, a syn-GH+ :T base pair is expected to
be less stable than a syn-GH+ :C base. Evidence for DNAP
ι using syn-GH+ :C base pairing exists [37]. 1,N6-etheno-A
directs both dCTP and dTTP incorporation, and in this case
both require a trapped proton [38], where the pKa values
of the relevant atoms trapping the proton are more equal.
Whilesuchthinkingisconsideredsatisfying[12],oneﬁnding
suggests that the situation can be more complex. DNAP ι
preferentially incorporates dCTP opposite the major adduct
of 2-acetylaminoﬂuorene (AAF-C8-dG) [93], Syn-AAF-C8-
dG places the bulky AAF-moiety in the minor groove, where
molecular modeling showed that it does not ﬁt, while anti-
AAF-C8-dG:C pairing, which places the AAF-moiety in the
spacious major groove side of DNAP ι, is possible [94]. The
authors propose that purine adducts with bulk on the minor
groove side probably use syn-purine pairing, but that purine
adducts with bulk on the major groove side probably use
antipurine pairing. Anti-AAF-C8-dG:C pairing requires a
modest change in sugar pucker (from C3 -endo to C1 -exo),
as noted in modeling studies with both DNAP ι [94]a n d
Dpo4 [95].
Base substitution rates on undamaged templates are
relatively high with all of these polymerases: yDNAP η (∼
10−2), hDNAP η (∼3.5 × 10−3), h DNAP κ (∼6 × 10−4), and
hDNAP ι actually prefers to form template-dT:dGTP; indel
mutation rates are all in the same range (∼1–2.4 × 10−3)
(reviewed in [7]).
4.Y-FamilyDNAP MechanisticSteps
A number of comprehensive reviews have appeared that ana-
lyzethestructuresofY-FamilyDNAPs[10–12,32,33].Inthis
section, we focus on what is known about protein structural
changes that occur during DNA synthesis as probed via X-
ray structural analysis and other techniques, principally with
Dpo4. The chemistry of catalysis is also considered.
Upon DNA binding to Apo-Dpo4, the thumb/palm/
ﬁngers domains do not change their structure dramatically.
However, the little ﬁnger domain acts like a door, which
is open in Apo-Dpo4, and then rotates ∼130◦ to close
around DNA; in particular, it binds in the major groove
in the duplex region from about L + 3 to L + 8 [33].
This motion is facilitated by the fact that the little ﬁnger is
connected to the rest of the protein by a simple ten amino
acid tether. Once binary-Dpo4 is formed, the palm, ﬁngers
and little ﬁnger translate ∼3.3 ˚ A along the helix as the next
template base slides into the active site, which opens the
space into which the complementary dNTP binds to give
ternary-Dpo4 [32]. The thumb domain, however, does not
move in this step, but, rather, moves either before, during,
or after the subsequent covalent reaction step. A variety
of subtler changes in Dpo4 structure are also reported to
accompany these steps [32, 33]. Kinetic studies reveal that
Y-Family DNAPs have a rate-determining conformational
change before dNTP incorporation [10, 96], and three
conformational states E, E
 ,a n dE
   have been reported,
where the E
  → E
   conformational transition is rateJournal of Nucleic Acids 5
determining, though the nature of these states have not
been identiﬁed. Recently, hydrogen-deuterium exchange in
tandem with mass spectrometry has been used to study
conformational changes in Dpo4 brought about by dNTP
binding [30]. Correct dNTP binding aﬀects the structure
of a loop between the B-helix and the C-helix above the
Dpo4 active site. (The positioning of these features can be
inferred from the UmuC(V) sequence in Figure 2.) Another
conformational change was also detected in the H-helix,
which contacts the primer strand and was proposed to
move away from the active site in conjunction with ds-
DNA movement to permit room for correct dNTP binding.
The F-helix also moves, but this motion is not speciﬁc for
the correct dNTP. In terms of lesion bypass, Dpo4 showed
decreased catalytic eﬃciency with increasing bulk of N2-dG
adducts,whichwasattributedmoretotheeﬀectsofthebulky
lesion on the rate of the catalytic step than on the rate of the
conformational steps [31].
Several studies have shown that dNTP incorporation
is more dependent on base:base hydrogen bonding for Y-
Family DNAPs than for DNAPs in other families during the
replication of both undamaged and damaged DNA [97–99].
The steps in covalent catalysis by Dpo4 have
been explored using a combination of molecular
modeling/dynamics and ab initio QM/MM minimizations;
a novel water-mediated and substrate-assisted mechanism
was proposed [100]. In the ﬁrst step, a water molecule in
the active site serves as a conduit to deprotonate the primer
3 -OH and protonate an oxygen on the α-phosphate of the
dNTP. In the second step, a second water molecule in the
active site serves as a conduit to deprotonate the oxygen on
the α-phosphate of the dNTP and to protonate an oxygen on
the γ-phosphate. Following these two steps the deprotonated
3 -O− of the primer is a stronger nucleophile and attacks the
α-phosphate, while the second water molecule serves as a
conduit again—this time to deprotonate the γ-phosphate of
the dNTP and to protonate the β-phosphate, which is on the
pyrophosphate leaving group, thus facilitating its removal.
5. The Steps Leadingto Translesion
SynthesisinE. coli
A well-developed model for the steps in translesion synthesis
has emerged for E. coli [107]. Replicative DNAP III stalls at
many adducts. For example, in the case of AAF-C8-dG, the
3  → 5  exonuclease activity of DNAP III competes with
its polymerase activity, such that [L-1]:[L0] ratio is ∼10:1
ratio of primers, as determined in vitro [66]. A TLS-DNAP
probably helps dissociate a stalled DNAP III from the lesion
site (see below). DNAP III reinitiates replication hundreds
to thousands of base pairs downstream of the adduct/lesion
at the next primosome assembly site in a process called
“replication restart,” either on the lagging strand using the
normal lagging strand machinery (i.e., PriA/B/C, DnaB/C/T,
and primase), or on the leading strand, whose details are
being worked out [108, 109]. This leaves an ss-gap between
the lesion site and the site where DNAP III did replication
restart.ThisgapiseitherﬁlledviarecombinationorviaDNA
replication, which begins with the action of TLS-DNAPs
[15, 108, 109].
DNAP IV binds β-clamp to help release a stalled DNAP
III from the same β-clamp, leaving DNAP IV/β-clamp at
the site of the lesion [110]. This process is rapid (t<15s).
Presumably, a similar mechanism operates for each TLS-
DNAP (II, IV and V), which all have β-clamp binding sites
(consensus: QLxLF) that are required for them to be active
in E. coli [111]. An X-ray structure shows that the underlined
amino acids QLVLGL at the C-terminus of DNAP IV form
the main interactions with a “cleft” in the β-clamp [112].
The α-subunit of DNAP III and the δ-subunit of the γ-
complex also bind to the cleft in the β-clamp. DNAP IV
and V can also bind to a site in the “rim” of the β-
clamp, but this seems unimportant for TLS [113–115]. In
vitro studies show that β-clamp stimulates both polymerase
activity and processivity of TLS-DNAPs: the addition of β-
clamp in vitro increases DNAP IV activity ∼2000-fold and
processivity from 1 nucleotide to ∼400 nucleotides, and also
increases DNAP V activity ∼100-fold and processivity from
1-2 nucleotides to ∼18 nucleotides [22].
What factors aﬀect the choice about which TLS-DNAP
will insert opposite a particular lesion? Several lines of
evidencesuggestthatE.colihasahierarchyforthereplication
of normal, unadducted DNA when DNAP III is inactivated:
DNAP II > IV > V[ 116]. (The assays did not permit an
assessment of DNAP I.) Since this order (III > II > IV > V)
does not reﬂect the relative concentration of these DNAPs
in cells (see above), another mechanism for decision making
was suggested, such as relative DNAP aﬃnity for the β-
clamp.ThisorderdoesreﬂectrelativeﬁdelityoftheseDNAPs
and would be a sensible order for E. coli to allow TLS-DNAPs
to initially sample adducts/lesions prior to a decision about
which will do TLS. But the ultimate decision is probably pre-
dominantly controlled by which TLS-DNAP is most eﬃcient
at bypassing a particular adduct/lesion biochemically.
After insertion opposite the lesion, additional extension
synthesis by a TLS-DNAP is required, or else DNAP III’s
proof-reading 3  → 5  exonuclease activity will remove the
inserted nucleotides back to the site of the lesion [66, 117].
The amount of extension required before DNAP III can
resume normal synthesis appears to be pathway dependent,
where it is [L + 4] for the AAF-C8-dG nonmutagenic
pathway with DNAP V, and [L + 3] for the AAF-C8-dG −2
frameshift pathway with DNAP V [66, 83, 117].
6.Two CaseStudies Showingthe Interplayof
Y-Family DNAPs inTranslesionSynthesis
More is known about the details of TLS for the major
adduct of N-2-acetylaminoﬂuorene (AAFC8-dG), and N2-
dG adducts in E. coli than for any other adducts/lesions in
any other model system. In these cases, multiple translesion
DNAPs are involved in both the nonmutagenic and muta-
genic pathways, as outlined in this section.
AAFwasoriginallydevelopedasapotentialpesticide,but
it was abandoned when it was found to be a potent rat car-
cinogen[118].Followingactivation,AAFprincipallybindsat6 Journal of Nucleic Acids
Secondary 1 1 10 A 20 2 30 3 40 B 45
Comsensus M F A L C D V N N F Y A S C E R V F R P D L R G K P V V V L S N N D G C V I A R S A E A K
Percent 55 56 84 87 42 100 31 87 43 88 97 57 95 81 97 46 57 86 54 97 46 85 29 54 40 89 67 70 92 91 93 94 94 94 95 84 54 55 84 74 72 28 74 91 89
A A  t y p e hhulhDhsshYsSsEphhpPt h. ths l lVLSN N D Gshl uts . tA+
E. coli M FALCDVNAFYASCETVFRPDLW GKPVVVLSNNDGCVI ARNAEAK
A 34 0 346 5 40 0 58 8 35 6 0 236 13 47 0 9 41 1 5 6 41 0 47 2 3 22 7 23 4 8 1 1 2 1 7 5 53 2 346 45 0 116 10 372 1
C 1045 5 5 0 1 2 9 09 2 0 0 6 6 0 3 3 4 1 1 4 1010001 5 010421000000 3 4 4 2 1 511 9 70010
D 30000 4 1 1 0 1 9 0000000002 7 6 0 1 9 0 01 4 2 000001114 3 8 6 0000001 2 4 1 3 00
E 10000001000010 3 9 7 90030 3 303 8 4 1 3 0000021000000000 2 2 3 0 5 00
F 3 2 2 9 6100000 3 6 3 1 3 004002 3 5 3 001211310000000000600001020
G 00 2 8 000 4 3 0 1 4 00100000001900 2 2 2 0214067448 3 9 2 0000201110
H 010 2 1 00000000001000809039600000000110000002000
I 2 3 7 2 3 1 4 1 1 3 0 3 1 000010201 2 1 1 0 0001 6 1 6 050 7 8 8 7 2 3 000000 1 1 1 0 3 2 2 7 0200510
K 7000000 1 5 2000000 4 4 0250 3 506 1 1 9 1 6 6 0000110121000020 2 2 40 3 6 6
L 1 1 1 1 1 1 3 5 8 1 0 0 1 1 000100002 7 8 2 9 011 3 5 1 806 1 0 3 6 60 3 7 3 0000055 1 50700 2 6 1 10
M 2 2 4 08270400 2 2 0001028600130000602600000 1 0 000500210
N 2000002 3 5 8 1 7 5 000100040 7 4 0503 4 8 2 2100005 3 8 5 3 8 5 20 1 6 0000 8 8 6 2 000
P 9000000000000000000 3 9 7 01000 3 6 5 000110001000130 5 1 200
Q 100310122000006 7 9 00 1 8 0901 5 3 1 2 0000110210000030 1 1 3 7 01
R 300000022000100 1 9 0 33 2 2 0 1 1 40 1 2 1 1 3 1 3 5 00000256400000 3 0 4 0 5 2 103 9
S 1 2 00090 1 1 1 1 6 9 001 3 9 1 163 1 7 112 4 1032270011 3 8 2 1 1 4176155 62 2 9 6 8340
T 1 2 1 3 0000013008400 5 8 3001906 1 0 1 5 020327224242153 1 9 4132
V 6 2 520 1 7 4 0 1 2 1 4000 9 7 0 2 2 00 2 3 3 001101 3 1 4 1 2 2 7 6 2 8 9 3 7 7 900100 1 0 2 2 0 1 5 6 21 4 020 1 52
W 2800000000010000020003 0 2 5 0000000000000000000000
Y 1 6 9 00000000 3 9 7 000000201064100000000000000000 3 2 000
X 03322000000000000000 1 2200111002110100000001100
HYDRO 370 394 380 385 399 0 354 12 44 411 411 401 13 410 1 28 384 403 6 406 45 409 129 5 59 400 407 407 407 397 2 1 3 1 8 385 408 405 350 95 7 202 45 403 3
90 96 92 94 97 0 86 3 11 100 100 98 3 100 0 7 93 98 1 99 11 100 31 1 14 97 99 99 99 97 0 0 1 0 2 94 99 99 85 23 2 49 11 98 1
L O N G 1 3 003103 3 7 7 1 8 1 000206 3 1 3 75 3 1 7 1 6 30 2 3 1 1 1 7 3 1 5 100029 3 9 0 3 9 4 91 1 6 000 3 0 9 8 8 1 4 7 4 2 0 4 0 6
3001001 9 2 4 4 000001 7 6 21 7 7 0 1 505 6 2 8 7 7 000002 9 5 9 6 2040007 5 2 1 3 6 1 0 09 9
SHORT 37 13 0 3 10 0 14 379 353 0 0 9 397 1 12 374 27 6 318 4 113 0 240 129 332 8 2 0 4 5 398 403 400 14 10 26 3 6 61 314 403 159 46 7 408
9301203 9 2 8 6 002 9 7 03 9 1 71 7 7 1 2 705 8 3 1 8 1 20011 9 7 9 8 9 7 326111 5 7 6 9 8 3 9 1 1 29 9
Secondary 46 50 C 60 4 70 80 D 90
Comsensus A L G I K M G E P W F K I K D L L R R H G V V V F S S N Y A L Y A D M S N R V M S T L E E
Percent 52 70 87 64 48 75 80 25 94 41 86 50 29 48 26 37 22 23 33 37 51 63 25 49 59 94 89 94 85 34 94 100 46 70 57 96 22 86 60 73 21 30 64 46 28
AA type . h s l . h t . P h a p . p t . h . t . t l . h h S u N a t L Y u p h S t + h h t h h t t
E. coli ALGVKM GDPW FKQKDLFRRCGVVCFSSNYELYAD M SNRVM STLEE
A 214 39 1 0 55 9 30 67 5 23 0 4 39 15 42 19 33 14 30 21 4 8 69 97 4 0 21 0 0 139 1 0 188 7 1 2 65 6 3 18 65 8 13 58 17
C 010000300000 1 9 001 6 8 11 2 3 000 4 6 1 5 010010000200011 1 0 5100
D 1 0 030100 4 8 000110 1 0 5 1 6 18 1 2 3 2 2000000503100 2 8 8 00 1 5 100 1 6 0013 6
E 3 2 000 1 1 00 1 0 1 090 2 8 1 2 8 8 2 2 7 5 9 0 3 0 2 3 901 5 001030 1 1 8 005 3 1 00 2 5 400 4 5 40 1 9 0 1 1 5
F 3 1 9 2001 4 1 00 3 5 3 5 5 0600 2 1 6 6 1 3 030039 2 4 4 000 3 8 0320060005 3 1 1 00610
G 10 3 5 9 094 3 2 9 1 0 020010 1 0 00237 2 1 1 50001500800 1 7 0 103 1 1 003400 5 5 1 8
H 0150300200 2 3 312 3 1 2053 1 5 2 1 103 3 010023010 1 4 210 1 8 301 1 39034
I 1 15 0 262 0 0 0 8 0 17 0 1 118 4 0 41 66 6 0 2 1 99 72 30 3 0 0 2 0 2 3 0 8 0 43 0 1 0 22 9 0 84 79 0 1
K 3 4 0 1 0 1 1 9 6 3 8 1 1 3 012 2 0 5 2 1 9 7 2 3 2 6 8 6 0 5 5 3 4 4 202 2 02701023003409 2 901 1 4 00 2 1 1 7
L 16 289 0 33 1 1 0 3 5 34 1 14 41 6 0 153 89 32 3 29 0 34 10 12 63 0 0 0 0 0 385 0 5 0 99 0 3 1 27 2 3 59 265 8 5
M 1 1 0 000 3 1 0 0 1 9 0405510 1 9 703203260000 2 0 04000 2 3 6 0335 7 2 9 9 15204
N 60605221100030 2 2 61 1 3 3 3 2 6 4050030 3 8 7 18002 1 5 06 9 0 001 3 3 0 1069
P 2 1 010 7 0 1 2 01 3 8 6 00007 2 4 096 2 2 9 1 00010 1 0 1 6 01 2 1 000000000000002
Q 3 0 000 1 3 00 3 0 000 1 3 0 5 2 2 7 2 6 2 2 4 3 1 8 7 2 2 1 702 7 0200001005200 5 2 504 3 5 0253 2
R 17 2 2 0 30 14 5 5 7 1 3 16 4 122 25 34 16 93 134 14 18 0 22 0 42 1 1 9 0 2 0 0 1 3 1 0 64 355 0 3 30 0 0 33 65
S 1 3 1104904301000 1 6 218 1 0 2 1 21440 3 8 7 3 6 7 10 2 6 10 1 2 5 4 0 3 9 6 5 1 201 8 7 40 2 1 6 4
T 6400780 3 9 030200452530011 1 110010 7 9 4001142021 2 5 6 1 2 3 182 1
V 661 1 1 4 320 6 0 4 2 1 00 1 0 0 00 1 2 2 9 2110 2 5 9 1 0 3 2 0 0 1 0 1000110118020 2 4 6 1 7 1 0 1 0 9 2 1 01
W 040010000 9 2 20700100030013000000100000000010000
Y 0 1 2 3111000 1 6 8 2 1 0900247480180 2 2 000 3 4 8 03 4 0 9 0390020610 2 1 10
X 08 1 7 01000013222122 1 5 720042200000000000000000000
HYDRO 262 395 8 410 131 336 74 158 400 394 379 24 344 33 66 269 371 81 64 101 15 404 268 404 361 11 38 2 407 164 401 411 202 11 404 2 74 12 409 363 91 270 408 68 30
64 96 2 100 32 82 18 38 97 96 92 6 84 8 16 65 90 20 16 25 4 98 65 98 88 3 9 0 99 40 98 100 49 3 98 0 18 3 100 88 22 66 99 17 7
LONG 87 2 18 1 244 54 8 49 8 2 5 351 61 346 96 88 29 197 279 102 141 0 76 0 46 11 1 397 1 13 3 0 8 23 5 6 215 389 0 21 109 1 2 65 123
21 0 4 0 59 13 2 12 2 0 1 85 15 84 23 21 7 48 68 25 34 0 18 0 11 3 0 97 0 3 1 0 2 6 1 1 52 95 0 5 27 0 0 16 30
SHORT 106 7 19 1 255 71 8 92 11 5 6 353 61 346 116 95 32 210 292 123 143 2 91 5 47 398 368 399 1 118 8 0 20 78 6 406 268 391 2 34 252 128 3 94 208
26 2 5 0 62 17 2 22 3 1 1 86 15 84 28 23 8 51 71 30 35 0 22 1 11 97 90 97 0 29 2 0 5 19 1 99 65 95 0 8 61 31 1 23 51
Comsensus F A P R V E I Y S I D E A F L D L T G V P N C R D L T D F G R E I R A T V L Q W T G I P V
Percent 31 30 75 26 43 82 43 98 100 97 100 100 47 97 48 61 60 32 57 19 17 15 24 19 48 60 21 25 36 59 43 23 49 76 25 32 66 36 29 29 61 66 55 63 56
AA type h s s t . c . Y S I D E . F h p h t t . . . . . t . . . h s t t h p t t l h p . h t l s h
E. coli LS PRVEI YS I DEAFCDLTGVRNCRDLTDFGREI RATVLQRTHLTV
A 16 123 12 50 6 2 8 3 0 0 0 0 194 0 36 2 14 12 19 3 9 61 25 19 6 6 15 61 2 111 16 29 3 3 101 38 7 9 8 1 13 4 0 5 6
C 4 2 9 0460000000 6 7 0 5 2 3 1 2 10 2 1 009 7 1 2 9 0010 3 9 2005211001 9 1 2 0004 3
D 00 1 5 5 4 050000 4 1 1 0000 2 4 9 0 2 2 1 1 1 2 583 3 1 8 1 9 9 0 2 3 1 0 1 002 3 4 00 1 8 1 0 041 3600000
E 7 3 26 86 0 335 2 0 0 0 0 411 0 0 0 15 0 19 5 0 25 8 7 20 24 0 74 65 0 0 17 95 0 0 74 35 0 5 6 56 1 2 0 2 0
F 1 2 7 910381000006 4 0 0 70 7 1 00 2 8 2 872 4 1 6 0 2 1 1 1 3 1 4 8 02250100 1 10300000
G 08090000100020970 1 0 2 3 6 052 38 4 6 41181 2 4 2 1200310 1 012 0 0 2 7 3 010
H 1 3 01 2 7 4 3 6 000000000 1 0 03 2 4 093 2 1 3 908 2 0 4 3 1 0 4 3 9068 1 4 0 1 3 1 2 3 8 0 5 2 030
I 7421 5 9 0 1 7 6 20 3 9 9 0022 4 7 1 2 9 00 7 4 244 3 4 3 1 2 1 969120 2 0 3 718 1 1 2 413 3 8 0 1 6 4 06 1
K 2 0 21 50 0 4 0 0 0 0 0 0 0 0 8 03 84 0 93 643 01 32 0 2 11 02 6 5 202 9 4 4 3 303 2 1 0 27 0 3 0 0 0
L 107 1 2 4 48 0 1 1 0 1 0 0 20 1 198 8 247 2 1 35 12 16 18 8 0 245 15 9 57 2 19 26 131 3 2 18 19 147 2 4 56 0 226 0 6
M 5 4 000 1 7 3200000 3 0 0 1 4 0 1 2 00 2 8 901 2 5 042023 1 0 7 3 5 002021010501 3
N 863 1 7 01100000500 1 7 0 1 6 2 6 1 2 2 6 2 1 7 4 4 4 1 1 2 6108600 2 1 50164 1 03015
P 00 3 0 7 100 2 6 0000000040 1 5 1 0 0 7 192 3 2 8 8 3 3 2 1 9 010000000400000 2 5 7 0
Q 10 0 3 15 62 0 38 0 0 0 0 0 0 0 0 7 0 7 4 1 13 15 15 11 4 0 26 26 15 0 62 87 0 33 40 30 0 12 121 19 0 0 0 1 0
R 4 0 1 106 0 0 14 0 0 0 0 0 0 0 0 25 0 44 35 1 55 14 17 80 1 14 23 14 10 0 175 26 0 311 57 77 0 71 113 58 0 45 0 3 0
S 6 96 27 6 12 8 1 0 410 0 0 0 75 0 0 40 0 84 17 13 11 38 18 13 58 0 20 25 0 7 9 15 0 2 26 5 0 1 25 5 1 11 0 11 2
T 0 41 5 8 10 2 1 3 0 0 0 0 3 0 1 8 0 132 6 7 17 7 7 11 9 3 87 23 6 4 11 19 2 0 11 130 2 4 0 3 250 18 0 112 44
V 4 77 2 6 178 1 135 0 0 10 0 0 7 0 45 1 25 2 1 77 7 7 24 16 2 12 27 6 25 1 4 1 32 7 1 2 270 2 0 2 39 0 16 10 231
W 2 1 4 02120101000400000001000620 3 7 00000000 4 60 1 1 9 00000
Y 4 0 020581 4 0 1 00000426110 2 6 257 1 1 2 1 0 1 3 0 6 5 02105120 3 30700050
X 000000000000000003 1 2 9 5 8 0 5 8 1 0 2 1 9 2 3 1 9 310000000000000000
HYDRO 361 257 328 68 323 24 350 408 0 411 0 0 326 411 401 25 411 33 31 292 140 110 262 167 48 358 86 115 345 158 57 66 409 30 109 71 409 258 12 158 159 4 411 277 360
88 63 80 17 79 6 85 99 0 100 0 0 79 100 98 6 100 8 8 71 34 27 64 41 12 87 21 28 84 38 14 16 100 7 27 17 100 63 3 38 39 1 100 67 88
LONG 24 6 9 153 62 1 57 0 0 0 0 0 5 0 0 57 0 105 69 3 99 127 53 125 50 18 81 67 27 0 271 171 0 373 162 145 0 116 342 125 0 51 0 5 5
6 1 2 37 15 0 14 0 0 0 0 0 1 0 0 14 0 26 17 1 24 31 13 30 12 4 20 16 7 0 66 42 0 91 39 35 0 28 83 30 0 12 0 1 1
SHORT 30 143 41 167 84 11 59 3 410 0 0 0 83 0 1 105 0 321 92 23 127 172 78 149 117 21 188 115 33 11 291 205 2 375 199 280 2 121 367 133 251 80 0 128 51
7 35 10 41 20 3 14 1 100 0 0 0 20 0 0 26 0 78 22 6 31 42 19 36 28 5 46 28 8 3 71 50 0 91 48 68 0 29 89 32 61 19 0 31 12
Secondary 136 7 140 F 150 160 8 170 G 180
Comsensus G V G I A P T K T L A K L A N H A A K K - P P Q T G G V V D L S N P E R R R K L L A L L P
Percent 37 67 99 73 51 43 80 83 84 87 92 100 54 90 81 54 46 83 98 52 29 16 25 24 33 36 87 82 34 43 63 23 28 24 20 34 30 24 30 50 73 24 26 23 45
AA type s l G h u . o h s h A K h u s h h u K p . . . . . t s l h . h . . . . . . . . h h t . h .
E. coli GVGIAQTKTLAKLANHAAKKW QRQTGGVVDLSNLERQRKLM SALP
A 17 5 4 4 209 48 1 2 11 0 380 0 26 369 1 1 188 343 2 7 1 7 36 72 10 40 2 0 15 55 5 15 9 17 57 19 10 20 44 53 1 97 39 3 52
C 1 0 5 003011000208 2 7 00790001123005 1 1 2 52 1 0 3 1 1 80301306131
D 00000600000000 1 2 1 5 110801 2 1 9 1 2 1 3 0 000 1 7 5 0 7 7 1 0 7 3 3 5 3 3 1 2 6 6 2 4007303 6
E 00000 2 3 0008000007340 1 7 01 5 2 3 2 6 3 1 6 12070 1 8 9 7 4 8 4 3 4 9 6 8 1 900 3 4 823 0
F 020 2 6 010020004002 1 5 000 1 1411 7 1 104 5 7 2 1 9 101501015 1 2 01 1 20
G 154 0 407 0 186 2 0 0 6 0 0 0 0 10 2 5 3 0 1 1 3 1 0 52 3 146 359 1 0 0 0 21 11 12 10 5 1 2 3 0 0 27 6 0 5
H 000008001000000 2 2 0 000551 63 1 5 2 1 1 3 90251362 1 5 0241 7208 1 3 08
I 0 122 0 300 0 0 0 0 0 7 0 0 60 0 0 5 60 0 0 2 3 38 0 16 1 3 0 33 7 20 84 14 0 32 3 12 41 26 4 42 3 0 24 89 0
K 00000 1 2 0 3 4 0 000 4 1 1 000 3 3 21 4 0 4 2 1 4 11 0 3 1 2 5 5 2 0 01120397 2 2 4 2 9 3 1 1 2 4 10 5 3 2 6 41 6
L 0 6 0 29 0 1 0 40 6 357 0 0 222 0 1 5 68 0 0 2 10 20 11 0 33 1 0 9 39 15 258 4 3 29 12 16 45 22 5 206 298 3 105 93 5
M 000 2 1 00060200802090001001110512990102 1 0 334 7 6 38 3 00
N 000002 2 9 0000000 3 3 2 4030 1 3 02 6074 3 9 502 4 3 0 1 2 1 1 7 2 1 8 3 8 0 1 3 1 2006 1 5 07
P 00000 1 7 8 0 1 3 00000000000506 6 1 0 1 10 1 4 000023 1 0 9 8 1 6 1 1 9 11 200 1 5 52 1 8 6
Q 00000 5 8 001 2 6 0000 3 1 3100 3 3 06 58 9 9 7 2 7 8114047 2 3 2 8 2 6 8 9 2 0 1 600 3 5 5 7 3 21
R 1 5 0000 2 1 0 1 0 0900000 5 2 104 3 8 11 2 5 4 2 0 4 1 9 72710 2 1 1 1 2 4 1 5 1 4 0 1 2 2 9 9 7 030 3 5 3 9 65
S 99 0 0 1 16 26 51 0 9 0 28 0 28 5 18 0 0 33 0 8 0 17 18 27 16 31 5 2 5 7 0 96 39 4 23 13 3 7 7 0 1 74 17 1 51
T 2 1 0000 1 2 3 2 9 0 3 4 6 01000 1 2 0 1 1 1 5 0 3 4 198 1 0 1 3 6 106631 7 5 3 9 1 0 1 5 4 2 4 1 9 1 2303 3 0 7 62
V 0 2 7 5 0 2 6 0000 2 4 200 5 5 002 2 5 206 1 0 1 422600 3 3 9 1 4 1 6 3 1 0 1 5 2 1 6 1 6 8 1 1 534 4 222 5 45
W 000100000000000 3 1 3000 1 1 8 000700020 1 7 00007202 8 3 0 1 3 0 1 1 10
Y 01000 1 2 005000000 2 6 1 4 000 1 8 4 208 5 7 010 1 3 13160475561 5 53120
X 0000000000000000000 1 8 2 2 8 3 6 9 5 1 5 2 2 9 1 4 10109 2 3 1 5 76300000011
HYDRO 122 411 4 410 209 241 2 61 48 368 382 0 383 396 4 72 389 354 2 22 172 192 152 103 189 60 3 395 387 163 409 72 33 205 121 72 147 82 107 402 410 129 197 289 249
30 100 1 100 51 59 0 15 12 90 93 0 93 96 1 18 95 86 0 5 42 47 37 25 46 15 1 96 94 40 100 18 8 50 29 18 36 20 26 98 100 31 48 70 61
L O N G 1 5 0000 9 3 2 9 3 5 0 1 3 5 0 4 1 1 00 3 6 3 9 2 44 4 0 8 2 9 8 2 1 1 3 9 3 1 5 1 2 0 1 0 5 2 0 4 1 1 5 0 0 4 0 1 4 4 5 6 8 3 2 4 6 2 2 0 1 6 3 2 2 2 40 1 2 9 1 3 7 4 2 2 9
40000 2 3 7 8 5 090 1 0 0 00 8 8 2 2 11 9 9 7 3 02 7 2 3 3 7 5 2 6 513 1 2 0 1 0 3 5 1 4 2 0 6 0 5 4 4 0 5 410 3 1 3 3 1 07
SHORT 135 0 0 1 16 131 409 350 356 35 29 411 28 5 393 92 15 52 408 340 3 139 119 188 172 137 25 12 22 60 1 211 222 70 121 263 247 189 241 7 1 206 184 119 82
3 3 0004 3 2 1 0 0 8 5 8 7 97 1 0 0 71 9 6 2 2 4 1 3 9 9 8 3 13 4 2 9 4 6 4 2 3 3 635 1 5 0 5 1 5 4 1 7 2 9 6 4 6 0 4 6 5 920 5 0 4 5 2 9 2 0
Figure 2: Continued.Journal of Nucleic Acids 7
AA type l t c l W G l G t p h t t h L t . . s l . s s h p h t t . s . . . h p p . h s l . h . + h
E. coli VDDVW GIGRRISKKLDAM GIKTVLDLADTDIRFIRKHFNVVLERT
A 17 25 3 0 0 0 0 2 4 15 1 101 62 11 0 41 139 10 1 0 6 1 284 41 22 0 206 22 142 10 33 48 17 45 9 30 16 9 0 5 5 7 38 1 2
C 20011010200200 2 0 002021082001830000000680010000
D 1 5 7 1 8 6 100002006701 2 6 8341 1 2301 2 3 8 00 9 6 0 1 4 0 2 0 2 5 500 1 9 100020010
E 0 1 0 1 1 7 8 00000400 2 9 3 4 40 6 4 2 0 670 2 4006 3 8 00 5 5 1 1 9 3 5 1 5 2 6 044 2 4 000 3 6 3 2 5 7 60
F 0019110030121 1 4 604602 1 200 2 0 0 5 6 070001 7 3 0001 2 6 7 0000000
G 0 1 1 6 101 3 9 6 1 4 0 2 860 3 1 750 1 0 1 5 5 3 4 6 0705 1 7 2009024 4 5 10563 1 0 1 0 5 01 1 0 9 200
H 01200000 2 5 0 1 4 2 1 3 1 8 0 1 4 2 1 3 30 3 810 1 0 3019580 1 8 1 3 033 7 6 09010050
I 6 6 20 9 7 01 2 1 6 004 1 0 6 0200 1 3 1 0 1 4 1 3 3 8 502 0 1046090 4 0 2 2 4 1 8 8 901206 5 2 7 2 4 712 0
K 0 18 18 0 0 0 0 0 25 70 3 9 183 194 0 24 22 15 5 0 100 7 0 19 3 0 24 10 11 7 2 37 2 3 44 237 43 0 0 6 1 0 9 24 0
L 18 0 1 18 1 0 1 0 0 0 127 7 7 11 372 4 39 76 0 5 15 1 1 194 1 346 4 10 35 0 21 6 79 75 5 2 31 37 0 3 12 178 41 3 68
M 3012020010 1 8 00752 1 2 1 5 6 02226 1 0 003 1 1 7 5 002 1 4 3 5 336 3 6007 3 2 1 4 01 1
N 0 2 1 800201 1 1 067 1 5 20 8 1 89 3 8 0 4 3 4 501000 5 2 0 7 0 1 2 1 5 0006 4 5 0 1 0 7 0 1 6 0170
P 30006000 1 5 00090001000001102000 9 1 1 3 3 1 0 8000003120000
Q 0 7 3 0 0 0 0 0 4 69 5 6 19 22 0 55 16 27 2 0 12 0 0 1 98 0 6 52 28 0 5 7 19 0 14 39 52 0 0 0 2 2 11 8 0
R 0 6 3 0 0 4 0 1 287 243 0 6 30 89 0 41 17 47 2 0 46 1 0 27 2 0 68 51 4 4 9 83 14 0 307 42 47 0 0 0 2 0 1 353 0
S 0 40 3 0 0 3 0 5 8 1 15 130 5 2 0 14 42 3 1 0 13 39 0 0 0 0 45 8 28 58 21 26 3 0 2 17 15 6 144 5 2 6 10 1 1
T 1 1 1 3 20000010 6 1 5 7 1 3 408 3 6 302 4 1 3 1 1 2030 2 4 1 0 5 2 2 6 3 2 3 3 0 003 2 9 14 35 4 3 421 2 9 6
V 290 4 1 282 0 0 192 0 2 3 1 15 3 0 0 8 14 3 0 58 3 0 84 1 1 1 19 0 2 0 11 9 13 64 0 0 14 3 0 321 251 43 11 0 12
W 0001 4 0 1 00000 3 1 00 2 8 000000000 1 9 0000000 3 4 6 3 0000 1 00000601
Y 0000020090 2 2 110766 1 3 10 3 100 4 0 0241 1 6 02571601 2 20003100
X 000000000000000000010000000000000000000000000
HYDRO 399 31 7 410 410 6 410 2 36 22 307 128 85 71 410 74 225 280 3 407 75 4 404 329 24 411 243 59 282 101 240 117 298 408 32 35 76 394 3 395 305 287 118 5 114
97 8 2 100 100 1 100 0 9 5 75 31 21 17 100 18 55 68 1 99 18 1 98 80 6 100 59 14 69 25 58 28 73 99 8 9 18 96 1 96 74 70 29 1 28
LONG 0 52 32 0 0 6 0 2 327 382 14 28 247 307 0 201 63 98 47 0 201 53 0 48 103 0 98 165 43 81 28 142 35 3 365 324 187 0 107 6 21 2 22 392 0
0 13 8 0 0 1 0 0 80 93 3 7 60 75 0 49 15 24 11 0 49 13 0 12 25 0 24 40 10 20 7 35 9 1 89 79 45 0 26 1 5 0 5 95 0
SHORT 11 105 37 0 0 9 0 7 336 383 90 215 265 313 0 223 141 104 48 2 255 403 2 48 106 0 167 183 123 141 112 191 68 3 367 344 231 7 294 16 66 12 34 394 297
3 26 9 0 0 2 0 2 82 93 22 52 64 76 0 54 34 25 12 0 62 98 0 12 26 0 41 45 30 34 27 46 17 1 89 84 56 2 72 4 16 3 8 96 72
Secondary 226 K 230 240 250 251 9 260 L 270
Comsensus V R E L R G E S C L E L E E F P P P K Q Q I V C S R S F G E R V T D EL E E L R Q A V A T Y
Percent 53 56 93 94 38 98 40 30 88 43 20 64 57 49 19 33 45 26 67 53 39 78 25 33 77 87 88 86 79 27 48 39 57 36 30 32 26 49 31 51 84 41 30 18 43
A A  t y p e ..E L p G ..sh .h p.....p p ph h so + o h u t.h tp h t.h.p sl..a
E. coli VRELRGEPCLQLEEFAPTKQE I I CSRS FGERI TDYPSMRQAI CS Y
A 39 13 0 15 12 1 4 87 3 6 37 1 12 10 80 89 86 84 9 3 7 0 40 12 7 1 1 16 19 14 16 1 10 14 10 44 56 5 23 16 345 4 122 35 0
C 11006010 3 6 3 3100030000001 5 6 8 1 3 4 030100221400004004 8 2 20
D 0660125 2 0 27 4 0 3 1 0 0 5 8 6 1 0 5 5 4 030000010028 1 6 3 1 1 1 4 6 0 7 8 6 5 017000 1 20
E 04 3 8 3 050 1 6 3 950 8 2 0 2 3 3 2 0 0 1 4 2 5 2 6 732 1 0 3 01051008 1 1 2 20 3 5 6 5 5 1 3 2 1 0 8 03 3 1 3 0 501 3 80
F 220000003 2 9 2 1 8 00 6 2 00000003 3 2000 3 5 2 010150 5 0 12390011 2 0 7 7
G 00001 4 0 2 110 1 0 3 5 081625400 2 301 3 15100 3 2 3 1 4 50311 1 2 1 0 152102 1 70
H 5 1 6 1 0 090 2 2 0091099411215000500000 1 6 10965 1 0 703 43600 1 3 1 3 1
I 4 5 00100 8 0 30 1 0 7 4 4 9 23 4 1 4 1 2 4000 3 2 2 6 9 30040020 1 5 2 91 4 0 29 5 4267 1 2 6 1 4 33
K 7 17 5 0 23 0 5 16 1 32 7 0 6 10 5 17 17 17 274 157 0 0 0 8 1 25 0 0 5 37 29 1 5 15 34 1 6 0 56 1 0 0 3 40 0
L 6 4 8 5 3 8 7 10822 1 7 6 2 2 6 1 2 3 1 1 5 3031101 7 2 5 1000 1 5 117 4 8 54 1 2 3 29 2 0 2 2 221 1 0 0 4 1 09
M 0 2 3 030060060 2 3 0170131011 1 2 4 100 1 5 514 3 0 1 0 70201 1 2 3 2007289
N 0 1 3 00 1 1 4 143156303 2 3 46631 1 300500008 1 0 20 1 4 2 3 1 1 4 6035007 1 51
P 0000000 1 1 2 30 5 8 405 1 2 1 3 7 1 8 7 1 0 8 420000010061 7 9 3017 2 9 2 3 02200000
Q 53 17 0 0 69 2 39 3 2 0 40 0 12 11 9 3 12 13 6 216 162 0 11 0 0 16 1 0 0 81 3 15 2 24 10 28 15 0 57 210 1 0 2 31 0
R 0 231 0 0 157 1 5 9 7 4 7 0 2 3 0 50 6 12 91 16 9 1 4 6 0 357 0 0 1 45 199 0 20 6 15 4 1 0 128 3 8 0 10 7 2
S 3 5 0 5 2 1 0 123 6 7 58 0 14 13 13 8 24 22 5 2 74 1 11 94 316 0 360 2 29 24 5 0 25 34 1 19 67 0 15 11 21 1 85 74 0
T 0 1 2 0 0 0 27 4 4 4 19 1 5 34 26 11 11 56 10 3 18 25 3 42 77 3 22 0 3 28 8 5 236 65 0 29 18 0 9 10 1 1 42 75 0
V 218 0 0 0 0 0 31 19 7 3 12 11 6 8 69 16 9 16 0 0 1 17 103 93 0 2 8 17 0 9 2 159 5 0 7 2 5 23 3 2 14 167 19 5 0
W 2 7 500 1 1 120100 3 7 000010000010000000201020001010102
Y 5900008013000082003002540003042 1 0 81 9 8 4302100 1 4 6 1 7 7
X 0000000000000 1 1 8 2 9 20000000000050110100000000000
HYDRO 343 101 5 406 30 2 140 223 383 333 116 404 22 58 297 251 296 218 18 6 9 384 368 250 7 7 28 409 27 36 140 386 51 25 339 84 108 410 70 29 368 409 259 89 277
83 25 1 99 7 0 34 54 93 81 28 98 5 14 72 61 72 53 4 1 2 93 90 61 2 2 7 100 7 9 34 94 12 6 82 20 26 100 17 7 90 100 63 22 67
LONG 60 278 5 0 363 4 53 31 11 41 60 3 20 27 37 74 41 48 374 390 184 1 15 19 1 398 1 0 14 173 233 16 41 68 60 47 28 0 244 219 9 0 22 93 3
15 68 1 0 88 1 13 8 3 10 15 1 5 7 9 18 10 12 91 95 45 0 4 5 0 97 0 0 3 42 57 4 10 17 15 11 7 0 59 53 2 0 5 23 1
SHORT 63 284 7 5 365 5 80 158 21 52 137 4 39 74 76 93 76 126 389 395 276 27 29 155 394 401 383 2 46 225 246 21 302 167 61 95 113 0 268 240 31 2 149 242 3
15 69 2 1 89 1 19 38 5 13 33 1 9 18 18 23 18 31 95 96 67 7 7 38 96 98 93 0 11 55 60 5 73 41 15 23 27 0 65 58 8 0 36 59 1
Secondary 271 L 280 11 290 300 12 310 315
Comsensus A A R A A E K L R K E G Q Y C R A I S V F I R T S P F A P N E P Y Y T N S A T V K L P T P
Percent 59 27 69 77 62 70 83 81 95 21 42 28 36 25 45 30 14 40 27 58 78 35 34 75 63 54 64 24 15 20 32 53 28 74 30 42 42 42 26 30 26 73 28 21 68
AA type s . . s s t + h R t p t . h s t . h . h h h p s s . a t . . . . . h . . t . . . . h . . s
E. coli AARAAEKLRS EHQYCRFI S TF I KTS PFALNEPYYGNSAS VKLLTP
A 244 109 1 317 253 28 3 35 3 47 3 5 3 14 152 24 57 0 19 22 4 62 6 2 7 11 1 100 17 13 15 31 1 3 51 15 44 174 32 21 28 2 29 12 87
C 2 7 21 3 0 2 1 00000214 1 4 1 8 7 1 0 2 2 01 1 1 005200110220 1 4 2208365000 2 11
D 0820013019 2 1 5020850100140 1 9 22 7 4 3 3 6 3 3 8 1 0 3046110090 1 9 1 00
E 0 5 8 1 6 00 2 8 9 300 1 8 1 6 2 1 7 040310501051071 1 2 6 3 1 3 1 3 1 74037731 4 5 4 1 7 03 2 30
F 0500250001102 2 3 00 5 2 104 3 1 9 1 10307 2 6 5 09110 3 5 1 3 1 3 1 9 4331 9 0 6 2 1 1 12
G 6 23 1 14 24 3 0 0 0 62 2 115 6 6 4 64 13 0 18 0 5 0 9 2 18 2 0 9 7 17 28 19 2 2 94 27 21 9 8 19 1 0 8 1 2
H 0 4 0 0 7 2 0 0 1 13 20 79 0 6 0 4 35 0 13 0 5 0 50 1 0 8 66 4 1 9 8 2 7 29 11 0 5 3 8 12 29 1 8 5 8
I 2 0 9 3 7 1320 1 5 010014206 1 6 6 1 0 4 9 0 1 4 3 000015530203140 2 9 1 9 4 5 3 1 4 2 5 3 10
K 0 1 20 0 0 11 342 0 5 87 8 47 6 8 0 74 10 0 1 0 4 0 80 4 3 21 1 33 40 20 13 11 28 0 18 27 25 14 1 10 106 1 3 0 0
L 8 1 4 2 1 5 180 3 3 3 0300 9 7 7 1 02 1 5 9 1 3 5 3 0 25 6010210 5 3 1 3 3 941159 1 8 1 9 1 3 2 3 0 2 8 0 3 00
M 8 1 0 11320 1 9 72014 1 0 15 1 0 5 1 1 2 096200 1 2 20011170112 1 091 0 58 1 3 69
N 0 16 13 0 0 7 1 0 0 16 1 38 1 1 0 16 6 0 2 0 2 0 14 27 84 11 3 32 10 84 3 10 9 2 18 174 11 5 1 0 4 0 8 22 0
P 0000000000000010000000006 2 2 0 12 5 7 64 2 1 8 1 4 03 1 8 3200 2 7 5 1 1 6 2 0 2 8 1
Q 0 2 6 700 1 0 800 3 6 1 7 4 3 3 1 4 8 2 4 0 1 4 3 1 0 2 8 0103 4 0240 1 5 1 7 2 1 8 1 1 1 1 4 2 1 5 3 4 3 4 1 571 3 2 7 06 1 11
R 0 0 283 0 0 15 44 0 389 53 11 57 10 28 0 122 24 0 25 0 4 0 139 0 0 70 0 62 17 18 25 5 27 14 16 43 21 40 4 14 46 0 5 19 1
S 7 63 10 2 56 10 2 0 0 56 3 12 118 8 12 55 29 0 112 0 23 0 33 38 258 10 0 47 22 7 7 14 6 10 125 9 173 11 106 3 24 0 30 10 7
T 3 2 3 4 1 3 2 1 8 42004113 1 3 4 6 8 3 7 0 1 0 3 5 7 41 9 1 3 3 0 9 1626 1 5 97 1 7 0790 2 6 3 7 1 0 7 2 8 6 1 2 3 7 8 53
V 5 9 2 8 3 2 9 1 9 43952006 6 9 61 4 9 1 0 2 1 6 2 3 8 0 1 0 7 011315 4 1 0 1 1 1 7 5 1 3 6 1 4 1 1 2 7 5 1 1 2 3 73 1 7 3 90
W 0100400000002500003020100100100030 1 4 0001400000
Y 00100 1 0 0001200 1 0 1 019070 2 665816 6 0 10030 9 8 3 0 6 464238501 5 37
X 00000000000000000000001 1 1 2 1 1 8333 1 4 2 6 3 2 7 3 0 422251 2 1 0 1 0 1 1 222
HYDRO 366 178 46 393 306 59 6 411 15 57 8 7 119 311 349 43 220 411 103 354 362 391 19 17 15 262 333 114 183 27 70 278 181 341 96 82 85 268 143 248 77 396 282 223 387
89 43 11 96 74 14 1 100 4 14 2 2 29 76 85 10 54 100 25 86 88 95 5 4 4 64 81 28 45 7 17 68 44 83 23 20 21 65 35 60 19 96 69 54 94
LONG 0 43 323 0 0 43 395 0 394 192 194 175 165 61 0 226 71 0 56 0 11 0 267 31 89 106 4 142 84 124 59 37 178 18 67 278 91 74 13 37 183 1 22 52 2
0 10 79 0 0 10 96 0 96 47 47 43 40 15 0 55 17 0 14 0 3 0 65 8 22 26 1 35 20 30 14 9 43 4 16 68 22 18 3 9 45 0 5 13 0
SHORT 39 140 346 4 74 57 399 0 394 252 198 188 286 82 58 289 137 0 271 57 38 19 313 378 348 122 6 195 121 140 73 68 184 35 201 287 290 122 226 68 268 3 89 147 12
9 34 84 1 18 14 97 0 96 61 48 46 70 20 14 70 33 0 66 14 9 5 76 92 85 30 1 47 29 34 18 17 45 9 49 70 71 30 55 17 65 1 22 36 3
Secondary 316 320 M 330 340 13 350 360
Comsensus T N D T R D I I K A A L R A L D R I W R P G H R Y Q K A G V M L G D F V P Q G V A Q L D L
Percent 73 27 75 48 44 31 48 39 22 59 77 18 24 24 65 26 28 61 38 43 28 75 27 44 79 21 89 70 91 81 42 77 18 59 57 14 30 16 32 20 21 75 42 38 86
AA type o t s s . . h h t h s . . . h t t h a . . t h . h . + h G l h h . t h . . . t . . . . t h
E. coli TQDSRDI INAATRSLDAIW QAGHRYQKAGVM LGDFFSQGVAQLNL
A 4 41 4 13 17 16 1 9 64 243 316 6 32 100 45 44 70 13 1 3 41 4 7 43 0 70 1 289 5 1 2 11 38 14 1 19 16 46 27 19 86 6 18 8 0
C 09 1 3 0 1 1 243156 1 4 0 5 7 0001120142000 2 0 19 1 4 1710 1 4 120720200
D 0 7 8 3 0 8 22 1 2 6 006003 1 1 00 1 0 5 1 0 005 7 0 2 82800000010 1 0 2 4 4 00 3 6 2 7 3 8 1 8 51 1 4 1 5 5 0
E 01111 6 6 00 3 2 606 4 1 20 6 1 2 6 204 8 3 1 16 1 8 0000 1 7 020 1 3 3 7 0 1 7 8 3 6 5 5 2 4 2 3 36 1 40
F 0011 1 3 1 2 3 5042024 2 0 004 1 1 4 0015 9 0 4 1 200000 1 5 60 1 1 9 5 3 0608 2 7 0 1 3 01 5
G 0202 1 0 303 1 1 4956 5 4 23 1 2 2003 3 0 8 1 1 2 0206 3 7 2 1 4 1 1 7 2 5 8 04 3 5 1 5 1 3 3 1 9 91 2 7 3 30
H 05523 1 2 12 1 8 1 0 04 1 5 009 2 1 01651 6 8 0 1 3 272010204 1 4 072753 8 1 8 07 1 70
I 2 0 0 2 31 19 197 160 0 31 13 13 5 26 14 4 3 250 1 7 0 0 36 1 12 13 0 38 0 56 57 5 26 0 43 37 0 3 1 21 23 7 10 0 8
K 00008 1 3 00 8 9 70 2 4 5 0 00 4 4 5 4 30 8 4 1 311 1 3 2 0 7 5 3 6 7 0202025059 4 8 2 0568 1 2 00
L 1 2 7 21 39 39 152 64 3 20 3 74 27 93 267 1 5 77 4 6 1 0 11 12 20 6 10 10 0 4 56 315 44 2 233 7 1 11 1 4 40 4 172 0 353
M 010082 1 6 3159 1 8 2 1 3 61063520210 2 0 0200 1 7 1 2 3 2 8 074010731421 9
N 0 1 1 3 2 4 3720 1 0 6 0 10 1 4 1 0 00 2 7 330 1 0 1 0 1 22704303030 2 9 1 6 02 1 9 1 4 2 3 1 7 102 9 80
P 0008 1 7 2007101 1 6 00 1 5 1002 1 1 7 04 2 0 000000003000 1 2 5 2 741 6 1 2 0 3 7 30
Q 1 105 1 2 11 17 0 1 47 7 0 41 40 9 1 32 37 5 0 68 13 3 2 16 0 85 2 0 0 0 0 0 28 6 0 35 17 67 29 29 26 309 30 7 0
R 0522 1 8 2 703 4 8 20 3 6 1 0 0 00 3 4 1 1 5 30 1 7 8 872 0 1 8 0 0 3 3 1 6 00040050 2 2 1 5 2 1 1 39 3 8 4 1 7 00
S 97 43 35 118 12 8 0 7 7 4 8 23 26 31 7 17 25 0 0 2 27 1 4 12 0 31 3 5 2 0 11 1 45 3 0 35 102 42 22 15 36 9 5 49 0
T 301 2 1 199 18 31 4 68 13 20 2 69 13 0 8 9 12 6 1 5 4 2 6 4 0 14 3 4 3 4 9 9 36 0 0 56 10 20 24 15 13 25 13 13 0
V 1 0 0 25 10 42 10 64 1 21 39 57 2 17 35 0 11 31 5 10 5 0 36 3 10 6 0 32 0 331 23 24 10 0 2 59 3 4 1 82 21 2 3 2 7
W 000100010000610100 1 5 7 10110000000301000100011100
Y 005450050 1 7 10313121 1 1 7 012 1 1 2 1 7 3 2 3 4 0 000162500 1 7 0211 4 1 7 0800
X 4445633333334333446 1 3 81 35 1 0 33455444466 1 8 1 1 1 2 1 4 4 4 1 5 1 0 1 0 1 09
HYDRO 8 53 30 75 151 123 403 314 77 347 389 183 95 312 390 67 92 383 403 36 167 9 272 99 406 157 11 391 6 402 332 396 168 17 405 210 147 102 35 178 221 41 268 15 402
2 13 7 18 37 30 98 76 19 84 95 45 23 76 95 16 22 93 98 9 41 2 66 24 99 38 3 95 1 98 81 96 41 4 99 51 36 25 9 43 54 10 65 4 98
LONG 1 223 27 7 208 39 0 14 244 17 0 115 200 9 1 137 209 14 0 340 44 23 35 235 0 197 388 0 5 0 9 0 59 32 0 64 60 150 85 60 71 321 61 105 0
0 54 7 2 51 9 0 3 59 4 0 28 49 2 0 33 51 3 0 83 11 6 9 57 0 48 94 0 1 0 2 0 14 8 0 16 15 36 21 15 17 78 15 26 0
SHORT 399 268 63 324 238 78 4 89 264 41 10 207 239 40 16 163 246 20 1 347 75 26 45 251 0 242 394 9 10 4 29 10 140 35 0 155 172 212 131 90 120 355 79 167 0
97 65 15 79 58 19 1 22 64 10 2 50 58 10 4 40 60 5 0 84 18 6 11 61 0 59 96 2 2 1 7 2 34 9 0 38 42 52 32 22 29 86 19 41 0
Secondary 181 190 H 200 I 210 J 220 225
Comsensus V G D V W G I G R R I S K K L N A M G I K T A L D L A D A D P R F I R K H F N V V L E R T
Percent 71 28 45 69 98 96 53 98 70 59 31 32 45 47 91 20 34 38 84 82 24 76 69 47 58 84 50 23 35 34 32 20 19 46 75 58 18 65 35 78 61 43 63 86 72
Figure 2: Continued.8 Journal of Nucleic Acids
A 1 12 16 43 81 19 10 64 13 17 59 80 6 2 76 92 2 0 48 2 0 85 2 2 0 10 7 45 3 7 12 285 103 33 8 8 39 15 21 4 112 4 2 20 52
C 072202220303001501360001000300004 2 5 11110010176
D 0 124 100 26 22 46 25 15 18 17 35 6 1 9 7 0 1 369 12 0 1 17 1 18 0 3 49 0 0 0 0 0 1 3 9 4 43 6 38 3 6 0 0 0 52
E 0 16 59 21 71 44 13 67 13 10 126 20 0 5 42 0 0 10 30 0 0 11 3 34 0 2 11 0 0 3 0 1 2 57 4 1 31 8 50 0 12 1 2 2 158
F 3 2 8 444205001003001 2 2 004030 8 4 04220 6 0 1 3 8 0112 1 3 0012 0 14080
G 0 1 1 1 0 1 3 2966 6 8 1 0 9504 1 4 006 4 3 001 314 3 6 9 2 2 1 7 11 2 7 0 8 6 1 2 6 2 2 9 0 0 2 7 62 40 2 9 2111 6
H 02672 1 0 5 2 2 1 5 1 4 8500 1 1 001 3 3 061 4 1 8 1 6 39 1 3 20 1 2 502606 1 2 943 1 8 0553
I 960 1 6 56 1 2 1 0 0661710 1 1 7 6 03 1 7 6 00200206 8 7 4 1 9 1 2 1 64 1 2 1 00010 1 1 302
K 0 5 1 2 14 16 27 31 93 19 30 80 3 0 57 1 1 0 49 0 4 25 132 2 8 109 17 65 4 23 4 0 1 4 10 5 27 60 49 0 37 0 162 10 18
L 41 5 3 14 9 16 25 6 0 7 4 0 363 7 10 17 162 2 8 140 0 8 4 6 0 13 0 6 180 10 99 6 11 7 9 49 3 0 2 2 3 23 2 0 4
M 3411214201301 3 4 3 22 8 6 026000 1 9 0402 1 1 480053 3 3 42004 3 1 0 000
N 1 8 9 51 30 4 14 9 48 28 9 14 0 1 17 0 0 2 14 0 351 15 6 8 7 20 31 4 0 3 0 0 4 2 5 2 31 17 22 2 6 3 17 2 28
P 0 1 6 2 4 2 3 2 6 1 3 8 2 3 8 6 01 3 5 1 0 002000001006031004 1 3 131 1 7 15 9 2 4 101 1 2 010
Q 0 12 10 19 34 44 25 18 24 15 32 69 0 10 63 1 0 2 39 0 4 49 31 1 1 6 3 11 0 22 2 0 2 150 5 3 59 105 63 0 83 3 8 81 34
R 0 2 11 59 4 1 3 5 1 2 7 9 5 6 1 6 6 51 03 20 0 13 802 23 7 1 8 5 1 00 1 5 6 4 8 06 28 11 0 2 73 72 0 4 27 31 80 1 6 9 2 3 7 3
S 0 7 49 27 26 9 31 18 10 170 9 19 0 8 36 11 0 1 22 1 3 17 3 47 6 28 32 38 0 14 14 8 71 24 12 8 43 10 40 0 35 3 13 16 11
T 0 13 14 16 31 14 21 16 5 17 9 12 0 3 18 98 4 0 49 8 3 21 2 0 0 17 2 189 0 20 11 1 7 21 1 34 25 6 19 4 18 9 4 0 3
V 0 3 1 38 16 13 4 10 1 1 2 5 11 0 8 156 28 0 0 49 0 0 4 2 0 4 0 6 109 21 23 4 18 18 1 24 11 0 5 0 2 4 2 1 2
W 1 2 0000050001000003000000 2 2 00000 4 7 2 7 01004000 3 3 7 00100
Y 1338603021100301 1 1 023050 1 1 0 02160 5 1 1 1 0606 1 2 000710010
X 15 151 98 65 23 16 16 17 22 17 17 17 15 15 15 15 15 16 16 16 16 91 17 19 17 17 21 17 16 17 17 17 17 19 21 75 30 32 25 25 24 22 19 19 19
Secondary 406 410 420 422
Comsensus M L S P R Y T T R W S D L P V V K
Percent 31 62 78 69 28 73 83 84 50 49 23 45 52 55 23 45 35
AA type . h s . t . . s t . . t h . . h .
E. coli M LSPRYTTRSSD LLRVK
A 1 1 0 5 84 18 2 13 7 3 37 1 0 9 16 97 4
C 0110 2 2 200903 1 0 20311
D 20609701 3 7 0 6 3 1 8 5 02304
E 4012503132 2 8 1 1 0 11 2 6 06
F 2 1 3011 1 5 240 2 1 1100126
G 1 0 7 14 19 1 0 4 0 1 16 7 0 3 5 1 11
H 4 5 301 1 3 90150600013 1 5
I 126090000 3 1 00 1 1 2 2 9 2 8 6 9 9
K 18 31 2 21 8 2 4 0 31 2 25 2 0 2 34 1 142
L 56 254 0 2 1 0 15 0 3 51 4 1 214 82 17 9 9
M 1 2 8 1 4 0000100420 1 5 4305
N 19 0 2 6 21 5 4 0 21 2 37 7 0 0 3 0 14
P 200 2 8 3 056100010 2 2 4 101
Q 2 23 12 3 3 90 0 02 401 7 3 60 01 201 6
R 36 71 1 23 117 2 0 0 204 1 27 0 0 0 74 0 85
S 9 7 322 6 40 10 6 14 31 20 94 14 0 1 6 2 14
T 4 1 44 1 3 1 341 345 1 0 12 2 0 0 44 2 11
V 053000202810 3 1 5 9 6 1 8 6 1 2
W 600008000 2 0 2 100 1 3 002
Y 2 0 0000 3 0 1 110 3 1 5000003
X 1 61 51 52 32 02 52 42 63 33 23 23 43 63 63 83 84 1
Secondary 361 370 380 390 400 405
Comsensus F D D N A P R P K S E A/K L M A V L D K L N A R Y G R G T L R F A G Q G I Q Q Q W Q M R R E
Percent 80 30 24 12 20 34 33 21 23 41 31 19 88 83 18 38 39 90 12 43 85 21 45 27 90 38 53 46 44 15 34 69 31 36 71 29 14 26 15 82 27 75 41 58 38
A A  t y p e h .......tt.tl.th h D th p.p .u .t.l..u .......h t.p tt
E. coli FDDNAPRPGS EQLMTVMDTLNAKEGRGTLYFAGQGIQQQW QMKRA
Figure 2: Preferred amino acid at the 408 amino acid positions in UmuC(V), which is the polymerase subunit of DNAP V. Top row: amino
acid numbering (every tenth residue) and the likely secondary structure based on alignment to other Y-Family DNAPs (β-strand, yellow;
α-helix, blue, turn, green). Second row: consensus amino acid. Third row: percentage of the consensus amino acid. Fourth row: consensus
type of amino acid, as codiﬁed in [101]( W e b s i t e :http://coot.embl.de/Alignment/consensus.html). Regions where the consensus is high are
highlighted in pink (all Y-Family DNAPs) or red (UmuC(V) only). Fifth Row: UmuC(V) sequence from E. coli. Rows 6–25 show the number
of amino acids of each type at each position using the conventional one-letter code. Row 26: We note that some UmuC(V) sequences have
slightlymore or fewer than 422 amino acids. The number of UmuCs with an amino acid missingat a position compared to E.coliis shown in
Row 26 (“X”). When an amino acid is present in a UmuC(V) but absent in E. coli, then the sequence is merely not included in Figure 2 (see
text). In terms of gaps, E. coli only has one position that does not conform to the majority of UmuC(V)s: E. coli has an amino acid at position
156 (W), which is not present in a slight majority of all UmuC(V)s (226/408). The 408 UmuC(V) sequences were taken (as of 6/21/10) from
the databases UniProt/Trembl [102]a n dH A M A P[ 103]. The sequences were aligned using MUSCLE [104]. Sequences were excluded for
three reasons: (1) they were incomplete (i.e., sequences without recognizable versions of the N-terminus and the C-terminus were excluded);
(2) they lacked any of the catalytic residues D6, D101, or E102; (3) they were redundant within a species (i.e., within a species if two UmuCs
had the identical sequence, then only one was included).
C8-dG, as do most aromatic amine mutagens/carcinogens,
where AAF and AAF-C8-dG have frequently been used as
models to probe the mutagenic and carcinogenic mech-
anisms of aromatic amines [117]. In E. coli AAF has a
majormutationalhotspotin5 -CG1CG2 sequencesinwhich
it induces −2 frameshift mutations [117]. AAF-C8-dG at
G2 (but not G1)c a u s e sa−2 frameshift mutation in a
DNAP II-dependent process, or causes no mutation in a
DNAP V-dependent process [117]. The current model is
that AAF-C8-dG at a replication fork exists in two diﬀerent
conformations [66, 117]. In one conformation, the adducted
dG moiety is in a −2 slipped intermediate, which DNAP II
uses for insertion, and then in the presence of β-clamp an
additional three extension steps (to L + 3) are accomplished,
at which point replication can be successfully continued by
DNAP III [66]. From a nonslipped intermediate, DNAP
V inserts dCTP opposite AAF-C8-dG and then extends by
adding four more dNTPs (to L + 4), after which DNAP
III can successfully continue replication [66]. These two
pathways are followed approximately equally in cells, though
by manipulating the concentration of DNAP II versus DNAP
IV,theratio[−2frameshift:nomutation]canbemodulated,
suggesting that the two conformations interconvert [93]. In
vitroin5 -CG1CG2 sequences DNAP II also does TLS to give
a bypass product that should ultimately yield a −1 frameshift
mutation,whicharenot,however,observedinvivo;recentin
vitro studies suggest that DNAP II cannot extend far enough
from the −1 frameshift intermediate, and, thus, the 3  → 5 
exonuclease activity of DNAP III degrades the intermediates
in the −1 frameshift pathway [66].
Molecular modeling has provided insights about how
lesion bypass might occur; for example, a modest alteration
in sugar pucker (from C3 -endo to C1 -exo) is required
before AAF-C8-dG can Watson-Crick base pair with dCTP
[94, 119]. Though this work was done in Dpo4 and hDNAP
ι, there is every reason to think that a similar conclusion
would be reached for DNAP V. Recently, X-ray structures
of the corresponding deacetylated adduct AF-C8-dG hasJournal of Nucleic Acids 9
been reported [32]. Regrettably, the structures do not reveal
insights about how dCTP might be inserted opposite AF-
C8-dG, but they do oﬀer a glimpse of more-or-less normal
Watson-Crick AF-C8-dG:dC base pairing in the L + 1,
which has the AF moiety in the opening on the major groove
side of Dpo4, and in the L + 2 position, in which the AF-
moiety is accommodated by a modest rearrangement in the
little ﬁnger domain.
Benzo[a]pyrene (B[a]P) is a well-studied DNA dam-
aging agent that is a potent mutagen/carcinogen and an
example of a polycyclic aromatic hydrocarbon (PAH), a
class of ubiquitous environmental substances produced by
incomplete combustion [120, 121]. PAHs in general and
B[a]P in particular induce the kinds of mutations thought
to be relevant to carcinogenesis and may be important in
human cancer [122–128]. B[a]P mutational spectra were
established with the major metabolite that reacts with DNA
(i.e., (+)-anti-B[a]PDE), in E. coli [129], yeast [130, 131]
and mammalian (CHO) cells [132]. Mutagenesis has also
been studied with [+ta]-B[a]P-N2-dG (+BP, Figure 1), the
major adduct of (+)-anti-B[a]PDE, and G → T mutations
predominateinmostcases(see[133]andreferencestherein).
DNAPs IV and V of E. coli are both involved in TLS
with B[a]P-N2-dG adducts, although they play very diﬀerent
roles. In studies with puriﬁed proteins, DNAP IV inserted
dCTP (>99%) opposite both +BP and its mirror image −BP
([-ta]-B[a]P-N2-dG) in a 5 -CGA sequence, while DNAP V
inserted dATP (>99%) [77]. This tendency is evident in E.
coli. DNAP IV is required in the nonmutagenic pathway with
+BP [72–75], −BP [75] and other N2-dG adducts [72, 76].
An amino acid change (F12I) at the conserved “steric gate”
(which excludes rNTPs) decreases dCTP insertion in vitro
opposite several N2-dG adducts and similarly decreases TLS
in vivo, which argues that DNAP IV does dCTP insertion
in vivo [72]. In the nonmutagenic pathway DNAP V is
required in addition to DNAP IV with +BP [73–75]. Why
are two DNAPs required for nonmutagenic TLS with +BP:
certainlesionsneedoneDNAPforinsertionandasecondfor
extension [134, 135]. Thus, if DNAP IV does dCTP insertion
[72–77], then DNAP V must do extension, which is sensible
givenkineticﬁndingswithpuriﬁedproteinsshowthatDNAP
V can be signiﬁcantly better than DNAP IV at the step
directly following adduct-G:C formation (i.e., extension) in
the case of +BP compared to −BP (discussed in greater detail
in reference [75]). Regarding the nonmutagenic pathway
with −B P ,o n l yD N A PI Vi sr e q u i r e df o re ﬃcient TLS [75],
suggesting it does both insertion and extension. In a 5 -TGT
sequence, DNAP V is required in the G → Tp a t h w a yf o r
+BP, while DNAPs II and IV are not, implying that DNAP V
must do insertion and extension [57]. However, in a 5 -GGA
sequence, G → T mutations were shown not dependent
on DNAP V and were not enhanced by SOS induction,
which implies no lesion-bypass DNAP involvement and
led the authors to propose that DNAP III was involved in
dATP insertion opposite +BP [73, 74]. Random mutagenesis
studies with [+anti]-B[a]PDE also showed the existence
of a non-SOS-inducible G → T pathway (discussed in
[57]), though the major G → T pathway did require SOS-
induction, implying involvement of a lesion-bypass DNAP.
7. Architectureof Y-FamilyDNAPs
Table 1 [44] shows that dNTP insertion opposite a variety of
adducts/lesions, including +BP, is remarkably similar for the
DNAP IV and DNAP κ pair, suggesting they are functional
orthologs. Insertion is also remarkably similar for the DNAP
V and DNAP η pair, suggesting they are also functional
orthologs. There must be structural reasons for the insertion
preferences of these DNAPs, though the key elements are not
obvious, given that in alignments, for example, UmuC(V)
shares only 20% amino acid identity with its functional
ortholog hDNAP η, which is about the same as the 21%
identity that it shares with its nonfunctional ortholog
hDNAPκ[44].Theextentofthisdilemmaisfurtherrevealed
by the fact that hDNAP η is no more identical to scDNAP η
(24%) than it is to hDNAP κ (24%). Nevertheless, a careful
examination of Y-Family DNAP structure suggests that key
structural features do exist.
A variety of architectural features are revealed by consid-
ering how B[a]P-N2-dG adducts must sit in the active sites
of Y-family DNAPs and how these structures might relate
to adduct processing [136]. To form an adduct-dG:dCTP
base pair, the B[a]P moiety must be in the developing minor
groove, since the adduction site (N2-dG) is in the minor
groove in a Watson-Crick base pair. On the minor groove
side, Y-Family DNAPs have an opening (or gap) next to
the active site between the ﬁngers and little ﬁnger domains.
This opening looks like an elliptical hole of varying sizes in
Dpo4 [24–32], Dbh [23], hDNAP ι [36–38] and in models
of DNAP IV and UmuC(V) [44], while it looks like a slot in
hDNAP κ [35]. It is not unreasonable to think that the size
and shape of this opening might inﬂuence dNTP insertional
mechanism given that the bulky B[a]P moiety must interact
with this opening on the minor groove side.
The character of this opening can be analyzed based
on a simple analogy to a “chimney.” Three regions of the
protein contribute to the chimney as shown in Figure 3(a)
forourmodelofDNAPIV:anupperlip(aa33–36,turquoise)
and a left lip (aa73–76, blue), which are in the ﬁngers
domain, while the lower lip (blue, aa244–247), is in the little
ﬁnger domain [136]. The UmuC(V) chimney is shown in
Figure 3(b).
Two features control the size and character of this
opening. (1) The amino acid side chains in the upper lip
(aa33–36 in DNAP IV) can be thought of as a “ﬂue,” which
either plug the chimney leaving a small opening or do not
plug the chimney leaving a large opening. The ﬂue amino
acids are present in all Y-Family DNAPs. (2) A “cap” may lie
over the top of the chimney opening. The cap is formed by
an insert of amino acids in the left lip of the chimney and is
only preset in DNAP η [39, 40].
First, we consider how the “ﬂue” amino acid side chains
inﬂuence the character of the “chimney.” Why do we think
that the chimney is a key structural feature that is likely
to be important for protein function? If the chimney is
important, then evidence for its importance should exist,
even in the case of UmuC where no X-ray structure exists.
We aligned 408 UmuC(V) sequences, and Figure 2 shows
the total number of each of the twenty amino acids that are10 Journal of Nucleic Acids


































































Figure 3: Structures of regions of ecDNAP IV (a), ecUmuC(V) (b), hDNAP κ (c), scDNAP η (d). (a) View from the minor groove side of
DNAP IV (yellow), showing the “chimney” opening (cleft or hole), which is deﬁned by the upper lip (turquoise, aa33–36), left lip (blue,
aa73–76) and lower lip (dark blue, aa244–247). The chimney opening in DNAP IV is large enough to accommodate the pyrene moiety
of +BP (red). In DNAP IV, the dG moiety of +BP can base pair comfortably with dCTP in the canonical S1-dNTP shape. (Neither the
dG moiety of +BP nor the dCTP are visible.) The template (gray) and primer (brown) are also shown. (b) Models of UmuC(V) with no
adduct (B/left) or +BP paired with dCTP in the canonical “chair-like” S1-dNTP shape (b/center) or +BP paired with dCTP in the non-
canonical, “goat-tail-like” S2-dNTP shape (b/right). The chimney opening is small (b/left) and the pyrene moiety of +BP does not ﬁt into
the chimney such that the S1-dNTP shape is possible (b/center). In contrast, the pyrene moiety of +BP ﬁts under the chimney opening in
the case of pairing with dCTP in the S2-dCTP shape (b/right), because it sits lower down in the active site compared to S1-dNTP. (c) Regions
of hDNAP κ. Y-Family DNAPs in the IV/κ-class have a glycine “ﬂue-handle,” such as G131 (turquoise, c/left) in hDNAP κ G131 adopts
φ/ϕ-angles that lead to upward curvature of the protein backbone in the chimney upper lip (red arrow, c/left) and results in the “ﬂue” amino
acids (S132/M133, blue, c/center) pointing away from the chimney, giving a large opening. The c/right structure shows V130 (white) that
serves as a scaﬀold to organize the chimney’s upper lip and left lip (yellow ribbons), along with the roof-aa (S137, purple), the steric gate
(Y112, red) and a conserved tyrosine (Y174, brown), which stacks on the backbone of the left lip and helps orient it. V130 forms a square
with the G131 ﬂue-handle, L136 (gray) and the S137 roof (pink) upon which I166 stacks (dark gray). (d) Regions in scDNAP η. Y-Family
DNAPs in the V/η class have a bulky “ﬂue-handle,” such as V54 in scDNAP η (turquoise, d/left), which causes downward curvature of the
chimney upper lip (red arrow, d/center), and results in the “ﬂue” amino acids (Q33/W34, blue, d/center) plugging the chimney, giving a
small opening. The structure in d/right shows scaﬀold C53 (white) organizing the chimney’s upper lip and left lip (green ribbons in (c)),
along with the roof-aa (I60, purple), the steric gate (F35, red) and a conserved tyrosine (Y131, brown), which stacks on the backbone of the
left lip and orients it. C53 forms a square with the V54 ﬂue-handle (turquoise), I59 (gray) and the I60 roof (pink). scDNAP η has a large
insert/loop (aa96–126) in the left lip, which is represented as a discontinuity. (e) The upper lip for hDNAP κ (yellow) is superimposed on
the upper lip for scDNAP η (green), which clearly shows the diﬀerences in curvature. X-ray coordinates are from 2OH2 for hDNAP κ [29]
and from 1JIH for scDNAP η [27], where hydrogens were added using insightII.Journal of Nucleic Acids 11
foundat eachaa position. Positions with ≥90% aa homology
orwithclustersofhighhomologyarehighlightedinpinkand
red. Many of the ﬁrst ∼20aa show high homology, including
the presumptive catalytically essential aspartate (D6), and
the steric gate (Y11). The region around the catalytically
essential asparate/glutamate pair (D101/E102) is also highly
conserved. These and other regions that are conserved in all
Y-family DNAPs are highlighted in pink in Figure 2. Regions
conserved in UmuC(V), but not in other Y-Family DNAPs,
arehighlighted in redin Figure2. One suchconservedregion
is V29-C36, which is part of a loop that includes one edge
of the chimney lip (S31-D34). (This loop is discussed at
greater length in Section 7.1). A second conserved region is
S71-Y77, which includes the second lip of the chimney, as
well as other features discussed below. This conservation is
strong evidence that the nature of the chimney opening is
important. The third edge of the chimney (E255-T258) is
in the little ﬁnger domain, and in our model of UmuC the
third lip is farther from the active site and appears less likely
to impinge on adducts protruding from the minor groove.
Consistent with this view the third lip of the chimney is less
well conserved. Preliminary analysis of the chimney lips of
large collections of DNAPs IV, κ,a n dη sequences also reveal
considerable amino acid conservation of the chimney lips.
7.1. Structural Basis for a Large versus a Small Chimney
Opening. DNAP IV has a large chimney opening (Fig-
ure 3(a)), which can accommodate the pyrene thus allowing
+BP to readily pair with dCTP when dCTP adopts the
canonicalshapeobservedinallotherfamiliesofDNAPs[136,
137]. In contrast, UmuC(V) has a small chimney opening
(Figure 3(b)), which forces +BP downward in the active site
into a position where catalysis seems unlikely to be facile
[136, 137]. What structural diﬀerence(s) in DNAP IV versus
UmuC(V) might result in a large versus a small chimney
opening, and is this structural diﬀerence(s) conserved in
other Y-Family DNAPs in the IV/κ-class versus the DNAP
V/η-class?
The chimney upper lip (turquoise, Figure 3(a)) is closest
to the active site, and principally deﬁnes whether the
chimney can accommodate the bulky B[a]P moiety. The
ﬁrst amino acid in the upper lip of E. coli DNAP IV is
glycine (G32). We have collected 434 DNAP IV sequences
from the literature, and 418 have glycine at this position.
Furthermore, 13/13 DNAP κ proteins from diﬀerent species
have glycine at this position. The one X-ray structure
for the IV/κ-class is hDNAP κ [29], which shows that
this glycine (G131, turquoise, Figure 3(c)), is followed by
upward curvature of the chimney upper lip (red arrow,
Figure 3(c)/left). This glycine can be thought of as a “ﬂue-
handle” whose φ/ϕ-angles permit this upward curvature (see
below), with the consequence being that the R-groups on
the next several amino acids (the “ﬂue”; S132/R133, blue in
Figure 3(c)/middle) point away from the chimney opening,
which remains open. Our models of DNAP IV also have this
upward curvature (Figure 3(a))w i t ha no p e nﬂ u e ,w h i c h
depends on the analogous glycine ﬂue-handle (G32).
In contrast, leucine (L30 in Figure 2) is the ﬂue-handle
in UmuC(V) in 370/408 cases. Furthermore, 11/11 DNAP
η proteins from diﬀerent species have a bulky valine at the
ﬂue-handle position. The X-ray structure of scDNAP η [25],
which is in the in the V/η-class, shows that its bulky V54
ﬂue-handle (turquoise, Figure 3(d)/left) is associated with
downward curvature of the chimney upper lip (red arrow),
whichforcesthe“ﬂue”(Q55/Y56,blueinFigure3(d)/middle
to plug the chimney. Figure 3(e) shows the upward curvature
of the upper lip of hDNAP κ (yellow) superimposed on the
downwardcurvatureforscDNAPη(green).InUmuC(V)the
sequence is slightly diﬀerent (VLSN), though the outcome
is the same: the bulky L30 ﬂue-handle causes downward
curvature,andanasparagine(N32)plugsthechimneygiving
a closed ﬂue (Figure 3(b)).
Upward versus downward curvature of the chimney
u p p e rl i pc a nb et r a c e dt ot h eφ/ϕ-angles adopted by the
ﬂue-handle [136]. The φ/ϕ-angles for the nonglycine ﬂue-
handles in scDNAP η, hDNAP η, hDNAP ι, UmuC(V), and
Dpo4 are all similar, resulting in downward curvature of the
chimney’s upper lip, causing the ﬂue to plug the chimney
and the chimney opening to be small. In contrast, Glycine
has greater ﬂexibility in its φ/ϕ-angles compared to all other
amino acids, and the glycine ﬂue-handles in hDNAP κ and
DNAP IV adopt φ/ϕ-angles unique to glycine that allow
upward curvature of the chimney’s upper lip, which keeps
the nearby ﬂue amino acids away from the chimney opening.
7.2. Roof-aa and Roof-Neighbor-aa. Another key diﬀerence
between the IV/κ-class and the V/η-class is the bulk of the
roof-aa(pinkinFigures3(c)/rightand3(d)/right),whichisa
positionally conserved residue that lies above the nucleobase
of the dNTP, as seen in the active site of Dpo4 [24–32],
yDNAP η [34], hDNAP ι [36–38], hDNAP κ [35], and
hDNAP η [39, 40]. Isoleucine is the dominant roof-aa in
UmuC(V) (227/408), with valine (156/408) being the next
most prevalent aa (Figure 2). In fact, compared to E. coli wt-
UmuC (100%), the mutant I38V-UmuC (137%) is slightly
more active in the nonmutagenic pathway with +BP, while
amino acids that do not branch at the β-carbon, including
leucine, show much lower activity [138]. Immediately after
the roof-aa in UmuC(V), principally alanine is found
(346/408). In the case of DNAP η from diﬀerent species, the
[roof-aa/next-aa] is [I/A] in 10/11 cases. In the yDNAP η X-
ray structure [I60/A61] form a hydrophobic layer above the
nucleobase of the dNTP.
In the collection of 434 DNAP IV sequences, there is
more variability at the equivalent [roof-aa/next-aa] posi-
tions: [S/T] is preferred (238/434, 59%), though any of the
nonbulky amino acids S, A, or T can be found at both the
roof-aa (434/434) and the next-aa (406/434). For DNAP κ,
the roof position is also principally S, A, or T (10/13) and
the next amino acid is always threonine (13/13). In X-ray
structures the threonine methyl group in Dpo4 (T45) and in
hDNAP κ (T138) sit near the roof-aa (A44 and S137, resp.),
and the hydroxyl of the threonine forms a hydrogen bond
w i t han o n b o n d e do x y g e no nP β of the dNTP.
When the [roof/next-aa] were mutated in wt-UmuC(V)
from [I38/A39] to the single mutants [I38A/A39] or
[I38/A39T], polymerase activity declined signiﬁcantly; how-
ever, the double mutant [I38A/A39T], is nearly as active12 Journal of Nucleic Acids
as wild type UmuC(V) [138]. I38A/A39T-UmuC has the
same sequence as wt-Dpo4 (A44/T45), which is in the IV/κ-
class. These ﬁndings show the importance to activity of the
coupling of the identity of the [roof-aa/next-aa].
7.3. The Interconnected Architecture of the Chimney and Roof
Regions. To understand the interconnected architecture of
the chimney/roof regions of Y-Family DNAPs, it is useful
to focus on a bulky aliphatic amino acid, which is highly
conserved V29 (374/408) in our collection of UmuC(V)
sequences. (In the equivalent position, all 434 DNAP IV
sequenceshaveeithervalineorisoleucine; valineispresentin
10/11 DNAP η sequences and in 13/13 DNAP κ sequences.)
This amino acid plays a scaﬀolding role as revealed in
X-ray structures [23–38] and in models [44, 136, 138].
Using hDNAP κ [35] as an example, this scaﬀolding valine
(V130, white in Figure 3(c)/right) is the beginning of a
loop that ends with the roof-aa, and the two form a
backbone hydrogen bond (scaﬀold-C=O:HN-roof). This
backbonehydrogenbondisalsoobservedinX-raystructures
from Dpo4 [24–32], scDNAP η [35], hDNAP κ [35], and
hDNAP ι [36–38]. The scaﬀold-V130 also contacts the ﬂue-
handle (G131) and L136 (Figure 3(c)/right, gray). Thus, the
base of this loop is anchored by a square of four amino
acids (V130/G131/L136/S137). In scDNAP η, this region
looks similar with C53/V54/I59/I60 (Figure 3(d)/right).
The square includes I31/G32/I41/S42 in DNAP IV, and
V29/L30/V37/I38 in UmuC(V). Evidence suggests that V29
and I38 are likely to be in contact in UmuC(V) [138].
Scaﬀold-V130 in hDNAP κ (white, Figure 3(c)/right)
also helps organize the steric gate (Y12, red), which face-
stacks with Y174 (brown), a highly conserved tyrosine whose
other aromatic face contacts the backbone of the left lip of
the chimney (i.e., aa168–171 in hDNAP κ), thus helping to
orient it. A tyrosine is found at this position in 406/408
UmuC(V) sequences, in 432/434 DNAP IV sequences, in
11/11 DNAP η sequences, and in 13/13 DNAP κ sequences.
7.4. The Chimney “Cap”. The interconnection between
the roof and chimney regions are similar in scDNAP η
(Figure 3(d)/right). However, the left chimney lip has an
insert (aa93–127), which is not shown in Figure 3(c) but
is indicated by a circle. In spite of this insert/loop, the
chimneyleftlipofscDNAPη resemblestheleftlipofhDNAP
κ (Figure 3(c)/right) and of other Y-Family DNAPs. This
insert serves as a “cap” over the chimney opening, such
that the chimney is completely closed. DNAP η always has
a cap, though its size varies (e.g., aa81–87 in hDNAP η).
Speculation about a role for the DNAP η chimney cap is in
the next section.
8. DNAP η StructureswithTT-CPDs
Recently, X-ray structures of yeast DNAP η [39]a n d
human DNAP η [40] with a TT-CPD were published, and
remarkable insights have emerged. Two template bases are
in the active site, with the base on the 3 -side base pairing
with the dNTP. When the 3 -T of the TT-CPD interacts
with dATP, the 5 -T of the TT-CPD is also in the active
site, and when the 5 -T of the TT-CPD is interacting with
dATP, then the normal base on its 5 -side is in the active
site. Undamaged DNA appears similarly. The T-bases of a
TT-CPD lie at an angle of ∼30◦ with respect to each other
and lack the usual twist between the base pairs; however, the
impact of these distortions are minimized by the protein,
such that the TT-CPD looks remarkably similar to a normal
pair of adjacent thymines. Watson-Crick pairing is observed
between the dATP and each T-base of the TT-CPD.
dATP adopts the canonical chair-like shape found in
all families of DNAPs (see Section 10), though the shape
is nuanced; for example, the angle of the A-base is tilted
slightly downward compared to other dNTPs in Y-Family
DNAPs in order to pair with the 3 -T of the TT-CPD. In
hDNAPη,theguanidiniumofR61interactswithphosphate-
oxygens on both the α-a n dβ-positions of dATP, which is
a unique interaction among Y-Family DNAPs. Interestingly,
the equivalent R73 in yDNAP η is ﬂexible and can be in
this position, or it can face the opposite direction and pair
with the extra template base in the active site; that is, the
base not paired with the dNTP. This arginine is one of the
most conserved amino acids in DNAP η, though the R73A
mutation in yDNAP η retains normal kinetics with respect
to both undamaged and damaged DNA, which suggests that
its most important role is not being revealed in studies with
a TT-CPD. In UmuC(V), which is the bacterial ortholog
of DNAP η, methionine (M51) is usually at the equivalent
position, though arginine or lysine are frequently present
(42/408) (Figure 2). The other highly conserved amino acid
in DNAP η is a glutamine (Q38 in hDNAP η and Q55 in
yDNAP η), which sits in the minor groove and interacts with
both O2-positions on the T-bases of the TT-CPD.
Why is DNAP κ inactive on CPDs, while DNAP η is
active?Anumberofstructuralelementsnodoubtcontribute,
but one important feature is that M135 in DNAP κ,
which lies two positions before the roof-aa, is too bulky
to accommodate both template-Ts of the TT-CPD. In the
equivalent position, hDNAP η has a glycine (G46) and
yDNAP η has a serine (S58), whose smaller size permits TT-
CPD in the active site. Thus, DNAP κ may have an amino
acid (i.e., M135) to minimize its activity on substrates meant
for the Vη-class of DNAPs. Similarly, one of the functions of
theﬂueandthecapforV/η-classDNAPsmaybetominimize
its activity on adducts that protrude into the minor groove,
which are substrates for IV/κ-class DNAPs.
9. Architectureof the Y-Family
Little Finger Domain
Y-Family DNAPs show considerable amino acid homology
in the thumb/palm/ﬁngers domains (approximately aa1–
230), which makes alignment in this region, including for
UmuC(V), unambiguous [44]. However, alignment of the
little ﬁnger domain is more problematic. X-ray structures
exist for the little ﬁnger domain of seven Y-Family DNAPs,
and their fundamental structure is similar. They show a
conserved secondary structure of β1-α1-β2-β3-α2-β4, whereJournal of Nucleic Acids 13
the four β-strands are aligned and anti-parallel, while the
two α-helices are aligned, antiparallel and cross-diagonally
over the β-strands. In spite of this structural conservation,
standard sequence alignment algorithms (e.g., ClustalW or
MUSCLE) do not correctly align the little ﬁnger domains of
these seven proteins.
Figure 4 shows the correct alignment based on the X-ray
structures (as described in the legend), including the little
ﬁnger domain of DNAP IV [112]. What features of these
sequences allow the structures to be conserved, even though
their primary amino acid sequences are not conserved? An
inspection of the X-ray structures reveals that little ﬁnger
domains are held together by a core of about twenty-one
hydrophobic residues, which are highlighted in turquoise
in the alignment in Figure 4 (H1–H21) and are shown
in a Dpo4 structure (Figure 5). Though hydrophobicity is
conserved at these twenty-one positions, the exact amino
acid is not. Dpo4, Dbh, DNAP κ, DNAP IV, DNAP ι,
yDNAP η, and hDNAP η have 19, 19, 17, 20, 20, 20, and
20 hydrophobic residues, respectively, at these 21 positions
(Figure 4).
A comparison of these seven proteins reveals that the
little ﬁnger domain has thirteen positions where an amino
acid side-chain can interact with a phosphate-oxygen. Nine
positions have a consensus lysine, arginine, asparagine or
glutamine, which can interact with a phosphate-oxygen
in the DNA backbone; they are designated L1–L9 in the
alignment in Figure 4 (red) to indicate that their R-groups
are “long.” They are also shown in the Dpo4 structure in
Figure 5 (red). Four positions have a consensus serine or
threoninethatcaninteractwithaphosphate-oxygen;theyare
designated S1–S4 to indicate that their R-groups are “short”
in Figure 4 (pink). They are also shown for Dpo4 in Figure 5
(pink).
In terms of DNA interactions, there are some nuances. In
severalcasesamino acids withlongerR-groups canalsoserve
at the S1–S4 positions (e.g., K301 in Dbh). Regarding S3,
S297/Dpo4,S297/DbhandS359/DNAPιclearlyinteractwith
the P + 6 phosphate-oxygen; however, T469/DNAP κ looks
like a rotation would be required for it to interact properly,
though it was counted as a positive. Q296 in DNAP IV might
be able to interact with P + 5, though DNA is not present
for deﬁnitive assessment and it is noncanonical, so it is not
counted. R285/DNAP IV and R283/Dbh (instead of N340)
might interact with P + 8, though DNA is not present for
deﬁnitive assessment and it is non-canonical, so neither is
counted.
Of the thirteen sites that can interact with phosphate-
oxygens (i.e., L1–L9 and S1–S4), Dpo4 and Dbh have
an appropriate amino acid at 13/13 sites and 11/13 sites,
respectively. In contrast, hDNAP κ, DNAP IV, hDNAP ι,
yDNAP η and hDNAP η have an appropriate amino acid
at 9, 8, 7, 8, and 7 sites, respectively. The higher level of
conformity for Dpo4 and Dbh undoubtedly reﬂects the
need for more interactions with DNA given that they are
from thermophilic bacteria and must operate at elevated
temperatures. The similar number of residues (∼8) for the
other DNAPs probably reﬂects that they operate at a similar
but lower temperature (i.e., 37
◦C), and if they had more
interactions they might bind DNA too tightly. We note that
an increase in hydrophobic residues in the hydrophobic core
was not expected for Dpo4 and Dbh, because hydrophobic




DNAP IV can pair dCTP with the dG moiety of +BP,
importantly because the bulky pyrene can be accommodated
in DNAP IV’s large chimney opening (Figure 3(a)). For
phosphoester bond formation to occur the distance between
primer-O3  andPα-dCTPmustbereaction-readyandcanbe
compared to the closest possible distance, a van der Waals’
contact (∼3.5 ˚ A). In models of +BP in DNAP IV [136],
the distance between primer-O3  and Pα-dCTP was ∼3.7 ˚ A,
which approximates a van der Waals’ contact, and, thus,
can be thought of as being “reaction ready.” The no-adduct
control had a similar primer-O3  and Pα-dCTP distance (∼
3.7 ˚ A).
In contrast, UmuC(V) does not give a satisfactory struc-
ture when +BP is paired with dCTP (Figure 3(b)/center),
because UmuC(V)’s small chimney opening forces the
bulky pyrene moiety downward. Asparagine-32 is the main
problem, and its side chain plugs the UmuC(V) chimney
leading to a clash with +BP. In the unadducted structure
(Figure 3(b)/left), N32 adopts its lowest energy rotational
conformer with respect to the Cα–Cβ bond. The presence
of +BP leads to a rotation about the Cα–Cβ bond (Fig-
ure 3(b)/center); however, no other rotation can get N32
any farther out of the way. Consequently, UmuC(V)’s small
chimney forces the +BP-dG in the template and its paired
dCTP to move downward such that the primer-O3 /dCTP-
Pα distance is elongated to ∼5.0 ˚ A, which is a nonreaction-
ready distance.
These observations provide a reasonable rationale for
why DNAP IV preferentially does cellular dCTP insertion in
cells:DNAPIV’slargechimneyopeningpermitsareasonable
adduct-dG:dCTP structure with reaction-ready distances
between primer-O3  and Pα-dCTP.
If UmuC(V)’s small chimney enforces a non-reaction-
ready distance between the primer-O3 /dNTP-Pα, then how
could UmuC(V) insert any dNTP opposite +BP? Recently,
we oﬀered a hypothesis [136].
X-ray structures from all DNAP families show a canon-
ical dNTP shape that has been called “chair-like,” and its
structure from T7 DNA polymerase is shown in Figure 6
(blue insert), which is also observed in most of the X-ray
structures of Y-Family DNAPs, including Dpo4 (“S1-dNTP
shape,” Figure 6, green). However, a second non-canonical
“goat-tail-like” shape (“S2-dNTP”, Figure 6, yellow) has also
been observed [26]. The goat-tail-like S2-dNTP shape can
lie lower down in the active site, and +BP paired with dCTP
in the S2-dNTP shape allows the pyrene to lie comfortably
underthesmallchimneyopeningofUmuC(V),whichallows
the primer-O3 /dNTP-Pα distance to be reaction-ready
(∼3.8 ˚ A).14 Journal of Nucleic Acids
Conserved L1 L2 S1 H1 L3 S2
Interaction site T+3T+5T+4 T+2 T+1
ssDpo4 242 R K S I G R I V T M K R - - N S R
ssDbh 243 K IPHGRYLTLPY--NTR
413 R K S M S V E R T F S - - - E I N
DNAP IV 240 R K S V G V E R T M A E - - D I H
299 P Q S F S E E D S F K K - - - C S
390 V K S M M S N K N L R G K - S C N
316 P K T I G C S K N F P G K T A L A
Conserved H2 H3 H4 H5 H6 L4 H7
Interaction site T+2
ssDpo4 257 N L E E I K P Y L F R A I E E S Y Y K L D K R - - - - - - - - I P
ssDbh 258 D VKV I LPYLKKA INEAYNKVN G ---------I P
427 K A E E Q Y S L C Q E L C S E L A Q D L Q K E R - - - - - - L K G
DNAP IV 255 H W S E C E A I I E R L Y P E L E R R L A K V K P - - - - D L L I
314 S E V E A K N K I E E L L A S L L N R V C Q D G R K P - - P R K P
406 S I V D C I S W L E V F C A E L T S R I Q D L E Q E Y N K I V I P
333 T R E Q V Q W W L L Q L A Q E L E E R L T K D R N D N - - D R V A
Conserved H8 H9 H10
ssDpo4 282 K A I H V V A V T E - - - - D
ssDbh 282 MR I T V I A IME D
454 R T V T I K L K N V - - - - N
DNAP IV 284 A R Q G V K L K F D - - - - D
340 H T V R L I I R R Y S S E K H
439 R T V S I S L K T K - - - - S
364 T Q L V V S I R V Q G D - K R
Conserved S3 L5 S4 H11
Interaction site P+6 P+6 P+8
ssDpo4 293 L D I V S R G R T F P - - - - - - - - - H G I
ssDbh 293 L DILSKG KKFK HG I
4 6 5 FE V K TR A ST VSS---------V VS
DNAP IV 295 F Q Q T T Q E H V W P - - - - - - - - - - - R L
355 Y G R E S R Q C P I P S H V I Q K L G T G N Y D
450 Y E V Y R K S G P V A Y K - - - - - - - G I N F
3 7 8 L SSLRR C C A LT-----------RY
Conserved H12H13 H14 H15 H16 H17 H18
ssDpo4 307 S K E T A Y S E S V K L L Q K I L E E D E R - - - - - K I
ssDbh 307 S IDNAYK VAEDLLRELLVRDKRR----N V
480 T A E E I F A I A K E L L K T E I D A D F P H P - - L R L
DNAP IV 308 - - - - N K A D L I A T A R K T W D E R R G G - - - R G V
379 V M T P M V D I L M K L F R N M V N V K M P M - - - F H L
468 Q S H E L L K V G I K F V T D L D I K G K N K S Y - Y P L
391 D A H K M S H D A F T V I K N C N T S G I Q T E W S P P L
Conserved L6 L7 H19 H20 L8 H21 L9
Interaction site T0 T+1 T+3 P+8
ssDpo4 331 R R I G V R F S K F
ssDbh 332 RRIGVKLDNI
507 R L M G V R I S S F
DNAP IV 330 R L V G L H V T L L
405 T L L S V C F C N L
496 T K L S M T I T N F






































Figure 4: Amino acid alignment for the little ﬁnger domains in cases where the alignment can be assigned unambiguously based on X-ray
structures of Y-family DNAPs. Alignments were done with FATCAT [105] and MAMMOTH [106], which agreed with visual alignment.
The six rows show the four β-strands (β1–β4) and the two α-helices (α1a n dα2). Yellow highlighting indicates residues in each secondary
structural block. Blue highlighting shows the twenty-one hydrophobic residues (H1–H21) that make up the hydrophobic core of the little
ﬁnger domains. Red highlighting shows consensus lysine/arginine/asparagine/glutamine residues that bind with phosphate-oxygens (L1–
L9). Pink highlighting shows consensus serine/threonine residues that bind with phosphate-oxygens (S1–S4). “Interaction Site” refers to the
nucleotide position of the phosphate-oxygen with which an amino acid is interacting, where “T” refers to template and “P” refers to primer,
and the numbering refers to the duplex portion of the DNA. The interaction site is not always the same in all structures in the case of amino
acids with long side chains.
Interestingly, the S2-dATP shape allows the syn-confor-
mation, such that syn-dATP can pair with adduct-dG via
a Hoogsteen base pair. In contrast, the syn-adenine base
in the S1-dNTP shape has steric clashes with atoms in
thedeoxyriboseandtheα-phosphate.Adduct-dG:syn-dATP
pairinginUmuC(V)gavereasonablestructureswithprimer-
O3 /dNTP-Pα distances of ∼3.6 ˚ A[ 136]. The S2-dNTP
shape appears to have accompanying protein components
that should allow phosphoester bond making and breaking
[136, 138].
Other G:A mispairings are also possible. In principle,
anti-dATP can pair with syn-guanine in adduct-dG, which
requires the pyrene moiety to be in the major groove. Anti-
dATP can also pair with antiguanine in adduct-dG in an
elongated mispair. Thus, there are scenarios other than the
one involving our syn-dATP:antiadduct-dG hypothesis.Journal of Nucleic Acids 15
Figure 5: The little ﬁnger domain of Dpo4, showing amino acids
whose R-groups contribute to the hydrophobic core (H1–H21,
turquoise). Furthermore, lysine/arginine/asparagine/glutamine
residues that interact with phosphate-oxygens are shown in
red (L1–L9), and serine/threonine residues that interact with
phosphate-oxygens are shown in pink (S1–S4). The view is toward
the four anti-parallel β1–β4 strands, and β1 begins to the right,
while the last amino acid in β4 is shown just below it. The view is
also into the face that binds duplex DNA, where the helix axis is







Figure 6: Side view of a dNTP in the “chair-like” shape S1-dNTP
(green) versus the “goat-tail-like” shape S2-dNTP (yellow). Key
amino acids (only D7, D105, and K159 are shown) from a Dpo4
structure adopting the S1-dNTP shape were superimposed on the
same amino acids in a Dpo4 structure adopting the S2-dNTP.
Spheres are divalent cations (S1-dNTP/red and S2-dNTP/brown).
S1-dATP from T7 DNA polymerase is also shown (insert, blue). X-
ray coordinates are from 1SOM-B for Dpo4/S1-dNTP, 1RYS-A for
Dpo4/S2-dNTP, and 1T7P for T7 DNAP.
11. UnusualArchitecturalFeaturesof Dpo4
Dpo4 is by far the best studied Y-Family DNAP, both
structurally and biochemically. Based on biochemical and
X-ray ﬁndings [28], Dpo4 insertion opposite +BP was
proposed to follow a “dislocation” or “templated” path-
way. Dislocation/templated insertion (see [135, 136]a n d
references therein) involves DNAP stalling at an adduct,
slippage to the next 5 -base along the template, which directs
incorporation (e.g., dATP insertion opposite the 5 -T in a 5 -
TG sequence context), whereupon the newly incorporated
dA slips back to form an adduct-G:A mispair, from which
extension yields the mispair that ultimately gives a G->T
mutation. Dpo4 preferentially inserted dCTP, dTTP, dATP
and dGTP opposite +BP in 5 -GG,5  -AG,5  -TG and 5 -
CG sequences, respectively, [28], which is consistent with a
dislocation/templated mechanism.
Though the dislocation/templated mechanism is attrac-
tive for Dpo4, considerable evidence both in vitro and in
vivo suggest that neither DNAP IV nor DNAP V follow
a dislocation/templated mechanism with +BP, as discussed
extensively in [136] and references therein.
Why might Dpo4 be diﬀerent than DNAPs IV and V?
Dpo4 is in the IV/κ-class, and it has a nonbulky roof-aa and
roof-neighbor-aa [A44/A57], as expected for the IV/κ-class.
However, Dpo4 has a very small chimney opening (discussed
below), which is associated with for the V/η-class. Thus,
Dpo4 is a hybrid with a roof similar to the IV/κ-class and
a chimney similar to the V/η-class.
Dpo4 has a small chimney opening, because its bulky
ﬂue-handle (C31) causes downward curvature of the chim-
ney upper lip and leads to a closed ﬂue (V32) [136]. In fact,
Dpo4’s chimney is exceedingly blocked: (1) the V32 ﬂue is
inserted deeper into the chimney than, for example, the N32
ﬂue of UmuC(V), and (2) M76, which is the second amino
acid in Dpo4’s left lip, also plugs the chimney. DNAP IV and
UmuC(V) have non-bulky G74 and S72, respectively, in the
position equivalent to M76 in Dpo4. Thus, the excessively
pluggedchimneyofDpo4forcesthepyrenemoietyof+BPso
far from the active site that base pairing via either S1-dCTP
or S2-dCTP is impossible; consequently, both the pyrene
and the dG moieties of +BP are forced to be extrahelical
with consequence being that pairing cannot occur with its
complementary dC [28].
As mentioned above, DNAPs η,I V ,η,a n dι have an
appropriate amino acid at 9, 8, 7, and 8, respectively, of
the thirteen sites that can interact with phosphate-oxygens
(L1–L9 and S1–S4). In contrast, Dpo4 and Dbh conform
13/13 and 11/13, respectively, which undoubtedly reﬂects the
need for more interactions with DNA given that they are
from thermophilic bacteria and must operate at an elevated
temperature. Thus, Dpo4 studied at 37
◦C, which is typical,
may give results that do not reﬂect correctly on aspects of the
mechanism of other Y-Family DNAPs, which have evolved to
operate at 37
◦C.
This analysis suggests reasons for caution when applying
conclusions from Dpo4 to other Y-Family DNAPs, especially
those purely in the IV/κ-class or the V/η-class. Perhaps Dpo4
evolved its hybrid roof/chimney structure to bypass a unique
set of lesions encountered by a thermophilic bacteria. Alter-
natively, perhaps the structure of Dpo4 at physiologically
relevant elevated temperatures is diﬀerent than at the tem-
peratureatwhichitwascrystallized(roomtemperature.)and
assayed (37
◦C), and this aﬀects its structure and behavior.
12. StructureofB-FamilyLesion-BypassDNAPs
This paper has focused on Y-Family DNAPs, though some
lesion bypass DNAPs are in the B-Family, including DNAP16 Journal of Nucleic Acids
II in E. coli and REV3 of DNAP ξ in many eukaryotic cells.
DNAP II inserts and extends the −2 frameshift intermediate
of AAF-C8-dG [66, 117], which must have two looped out
nucleotides as well as the AAF moiety protruding into the
major groove. Data also suggests that DNAP II and DNAP
ξ are involved in the bypass of interstrand crosslinks [45–
49], which must have a large oligonucleotide protruding
into the major groove during TLS. Though B-Family DNAPs
completely surround DNA, the structure on the minor and
majorgroovesidesareverydiﬀerent,asrevealedinstructures
of both E. coli DNAP II [139] and Rb69 DNAP [140]. B-
family DNAPs have a helical protein component that follows
and contacts the minor groove side of duplex DNA. On the
major grove side, however, a protein dome is present that
leaves a large open cavity. Though Y-Family DNAPs are open
to solvent on their major groove side, the solvent-exposed
DNA surface inside the cavity for DNAP II (∼400 ˚ A2, when
considering,for example, the template:dNTP base pair plus
the L + 1 base pair) is actually larger than with either DNAP
IV(∼230 ˚ A2)orU muC(V)( ∼130 ˚ A2).Itseemslikelythatthe
large cavity and solvent exposed region on the major groove
side of B-Family DNAPs may be essential for their ability to




+BP: [+ta]-B[a]P-N2-dG (Figure 1)
−BP: [−ta]-B[a]P-N2-dG
TT-CPD: Thymine-thymine cyclopyrimidine dimer
TLS: Translesion synthesis, which includes the
insertion of a base opposite a DNA adduct,
as well as subsequent elongation
DNAP: DNA polymerase
S1-dNTP: The “chair-like” dNTP shape
S2-dNTP: The “goat-tail-like” dNTP shape
aa: Amino acid.
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